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Hemin Acquisition in Bartonella quintana
Chairperson: Dr. Michael F. Minnick

Bartonella quintana, a Gram-negative bacterial pathogen, causes Trench fever, bacillary
angiomatosis and endocarditis. Transmitted by the human body louse (Pediculus
humanus corporis), the agent has a tropism for erythrocytes in humans. In vitro growth
requires an extraordinary concentration of hemin, and genomic analyses indicate several
potential uptake systems and iron-responsive regulators. Transcription of the hbp genes
(hemin binding protein genes) is responsive to alterations in available hemin and an
HbpA homolog in B. henselae reportedly functions as a hemin receptor in E. coli hemA
strain EB53. B. quintana hbpA was not able to complement EB53, indicating that it is
not a hemin receptor. A functional hemin receptor and coordinate uptake system is
encoded by the hemin utilization (hut) locus. B. quintana hutA was able to complement a
hemA mutation in E. coli EB53 and was shown to be TonB-dependent using an isogenic
E. coli hemA tonB strain.
Fur (ferric uptake regulator) has been described as a global iron-responsive regulator in
γ-proteobacteria. If expression is forced, B. quintana fur is able to complement an E. coli
fur mutant, but an endogenous promoter for the gene could not be located and native
expression in B. quintana was not detected. Overexpression of the iron response
regulator (Irr), a Fur family member, in B. quintana repressed hut locus transcription.
Previous studies showed that Irr interacted with a consensus motif, the H-box, in the
promoter of the hbp genes. A region with homology to the H-box consensus is present in
the divergent promoter between hutA and tonB and in the promoter region of hemS.
The fate of hemin in the bacterial cytoplasm is not well understood. HemS is a potential
hemin storage/degradation enzyme. Initial characterization indicates that HemS is able to
bind hemin in a 1:1 fashion with an estimated dissociation constant (Kd) of 5.9 + 1.7 µM.
Complementation analyses using Corynebacterium ulcerans CU712hmuO∆ strain have
not been successful but future experiments plan to use an E. coli chuS strain. These
studies have characterized the principal hemin uptake system of B. quintana, identified its
transcriptional regulator, and initiated investigation of a potential heme oxygenase.
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CHAPTER ONE
Introduction to Bartonella quintana and bacterial hemin acquisition

I. Bartonella quintana

A. INTRODUCTION
The genus Bartonella encompasses 31 species and 3 subspecies of Gram-negative
facultative intracellular bacteria that belongs to the α2-proteobacterial subclass (See
Table 1.1, p.18). To date, eighteen of these species have been solely associated with
nonhuman mammalian hosts, to date. Another 10 Bartonella species are implicated in
occasional reports of human illness suggesting incidental infection. In contrast, B.
quintana and B. bacilliformis utilize the human host as the primary mammalian reservoir
and have been recognized as human pathogens for a long time (89). Together with B.
henselae, these three species are the primary Bartonella agents of human disease (122).
Alternative mammalian hosts have not been identified for either B. quintana or B.
bacilliformis, but cats provide an alternative reservoir for B. henselae (121). Although B.
henselae has been detected in cat fleas (Ctenocephalides felis), transmission to humans is
believed to be mediated by the scratch or bite of a cat (189). Typical B. henselae
infections in humans result in cat-scratch disease, but complications can include
endocarditis, bacillary angiomatosis, bacillary peliosis, neuroretinitis and chronic
bacteremia (56, 121). Due to the restricted geographical range of its sandfly vector
(Lutzomyia spp.), infection with B. bacilliformis, which results in Carrion’s disease, is
less common but more serious than other Bartonella infections (89). Carrion’s disease
presents itself in two distinct phases. The initial phase, Oroya fever, is characterized by
severe hemolysis-driven anemia and fever. The next phase, verruga peruana, is
characterized by the development of vasoproliferative skin lesions (41, 89). Like B.
bacilliformis, B. quintana has been described as a ‘specialist’ based on its strict body
louse vector-human host cycle that lacks an alternative mammalian reservoir (4).
Transmission to humans is mediated by the human body louse (Pediculus humanus
corporis), which can also transmit the bacterial pathogens that cause relapsing fever and
typhus, Borrelia recurrentis and Rickettsia prowazekii, respectively (3). B. quintana
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infections cause trench fever and are currently re-emerging as ‘urban trench fever’.
Complications arising from B. quintana infection, like B. henselae, include chronic
bacteremia, endocarditis, and bacillary angiomatosis (57).

B. GENOME AND EVOLUTION
The genomes of four Bartonella species, B. bacilliformis, B. henselae, B. quintana,
and B. tribocorum have been sequenced. Common themes among all four genomes
include a core of 959 genes, a G+C content of 38.2 to 38.8%, and a low-coding density of
72.3 to 81.6% (52). In addition to being the first recognized pathogenic member of the
Bartonella genus and the most virulent, B. bacilliformis is thought to represent an ancient
lineage while the remaining two major Bartonella pathogens, B. henselae and B.
quintana, along with B. tribocorum appear to have evolved more recently. The crux of
this argument is that the ‘modern’ lineage, including B. henselae, B. quintana, and B.
tribocorum, have genetically acquired factors leading to attenuated virulence and
improved host adaption. Genomic analyses indicate that 66 genes required to establish
intraerythrocytic infection in a rat model are common to all four Bartonella species
examined. An additional 15 pathogenicity genes are shared by the representatives of the
‘modern’ lineage but are absent in B. bacilliformis. Fourteen of these 15 genes are
components of type IV secretion systems, which allows for the delivery of effector
molecules into host cells resulting in enhanced host adaptation (151). The acquisition of
these factors is a characteristic of the ‘modern’ lineage that may contribute to the
establishment and maintenance of chronic infections rather than the severe acute phase of
B. bacilliformis infection.
Direct genomic comparisons between B. henselae and B. quintana indicate that the B.
quintana genome is a reduced version of the B. henselae genome. Furthermore, both
genomes appear themselves to be reduced versions of Brucella melitensis chromosome I.
In particular, B. henselae has a 1.93 megabase pair (Mb) genome containing 1,491
protein coding genes, 301 of which are unique to B. henselae. B. quintana has a 1.58Mb
genome encoding 1,143 proteins, 26 of which are unique to B. quintana (4, 32). Like B.
quintana, B. bacilliformis has a small genome consisting of 1.44Mb encoding 1,283
genes (52). Reductive genome evolution is consistent with an intracellular lifestyle and
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vector-borne transmission (32). In the case of B. quintana and B. bacilliformis, it may
reflect the utilization by both species of restricted host-range insect vectors and the
human host. Alternatively, the genomic expansion observed in B. henselae and B.
tribocorum may reflect selective pressures unique to the cat and rat reservoirs,
respectively.

C. HISTORICAL BACKGROUND
Paleomicrobiological methods have been used to amplify B. quintana DNA recovered
from dental pulp removed from human remains that are estimated to be more than 4000
years old by radiocarbon dating (45). Likewise, B. quintana DNA has been recovered
and amplified from the remains of 7 Napoleonic soldiers and 3 associated body lice found
in a mass grave in Vilnius, Lithuania. Local records date the grave to the period of
Napoleon's retreat from Russia in 1812 (20, 137). Despite this evidence of its longevity,
the first published reports describing Trench fever occurred during World War I (WWI)
(57, 129). Second only to influenza as a leading cause of illness during WWI, Trench
fever affected an estimated 1 million soldiers (57, 122). Signs and symptoms were
somewhat variable, but typically consisted of possibly relapsing febrile episodes
accompanied by chills, headache, and body aches with a focus on the shin (177). The
end of the war brought with it improved hygienic conditions resulting in decreased
occurrence of trench fever. However, World War II (WWII) initiated another round of
epidemics resulting in continued interest in the causative organism of the disease (119).
Undoubtedly due to difficulties encountered during attempted in vitro cultivation of the
organism, B. quintana (then Rickettsia quintana later Rochalimaea quintana) was
initially thought to be a Rickettsial species (180). Nonetheless, B. quintana was
definitively identified as the agent of Trench fever with the fulfillment of Koch’s
postulates by 1969 (177, 181). The end of the WWII again brought improvements in
hygienic conditions that were not conducive to louse infestation or the transmission of
Trench fever resulting in diminished incidence of and interest in B. quintana that would
last for more than 2 decades.
Interest in B. quintana infections would be renewed again in the 1980s. Although the
authors were unaware of it at the time, a 1981 report of Pneumocystis carinii infections in
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five previously healthy homosexual men marks the first report of AIDS, which is caused
by the human immunodeficiency virus (HIV) (67). By 1990, reports of opportunistic
Bartonella infections in immunocompromised individuals resulting in the development of
angioproliferative skin lesions similar to the verruga peruana produced by B.
bacilliformis began to surface. The condition was called bacillary angiomatosis (BA)
(109, 142). B. quintana was isolated from the BA lesions of three HIV-positive
individuals in 1992 (95). Within a few years of this report, B. quintana was
simultaneously reported as a cause of bacteremia and blood culture negative endocarditis
(BCNE) in homeless populations in Seattle, WA, USA and Marseilles, France (44, 163).
More than a decade later, B. quintana is widely recognized as a significant re-emerging
agent of disease especially in inner city homeless populations and immunocompromised
individuals.

D. TRANSMISSION
B. quintana is found extracellularly in the gut lumen of P. humanus corporis and is
able to replicate and survive there. Infection does not affect the longevity of the body
louse and is not transmitted to louse offspring. B. quintana is excreted by the louse in a
biofilm-like matrix in feces where it survives for up to a year. Lice feed up to five times
per day on humans and release factors when biting that produce irritation and itchiness.
Transmission to humans is thought to occur when scratching generates breaks in the skin
that allow inoculation with the bacteria-laden louse feces (36, 82). Although uptake
occurs via an unknown receptor, B. quintana has been identified intracellularly in
erythrocytes in the human host. However, only a small percentage of red blood cells
were found to contain B. quintana in the blood of patients with chronic bacteremia. No
evidence of B. quintana-mediated hemolysis or anemia has been found. (145). B.
quintana also has a tropism for endothelial cells and is rapidly endocytosed into a vacuole
where it survives and replicates (26). The ability of B. quintana to infect erythrocytes
undoubtedly promotes immune evasion and transmission to the body louse. Likewise,
the ability of B. quintana to remain infectious in louse feces for long periods of time
undoubtedly enhances it transmission to humans. Thus the transmission cycle is a good
example of the adaptation of B. quintana to its unique and limited host-vector range.
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E. DISEASE AND EPIDEMIOLOGY
Re-emerging urban trench fever in HIV-negative individuals was described almost
simultaneously in the U.S. and France. Although somewhat variable, signs and
symptoms similar to classical trench fever were described in primarily homeless,
alcoholic, male populations. Chronic bacteremia and endocarditis were also noted in the
initial reports (44, 163). Although there were some issues with the species specificity of
the assay used, followup studies at a downtown Seattle, WA clinic for homeless and
indigent persons reported that 20% of its subjects were seropositive for B. quintana (83).
Since that time, numerous studies have been undertaken in order to estimate the
prevalence of B. quintana in homeless populations. Of note, the population at-risk for
urban trench fever and a variety of other infectious diseases, namely the homeless, is by
its very nature dynamic and difficult to identify, treat, and conduct followup exams on
(138). These facts may account for some variability in results. Alternatively, the
variability may be the result of environmental factors favoring epidemics at particular
time points with lower prevalence rates observed between epidemics. Finally, the studies
are significantly different from one another in terms of the diagnostic measures and target
populations. Collectively these issues result in a fairly wide range of prevalence. For
example, a 1997 study of seroprevalence rates with 221 samples taken from eight
charitable institutions dedicated to the homeless over the course of five months reports
positive serology in 1.8% of the population (147). A later study in the same area focused
on 71 homeless emergency room patients and reported that 14% had positive blood
cultures for B. quintana and 30% had high antibody titers (25). During an epidemic
typhus outbreak in a refugee camp in the East African Republic of Burundi, up to 12% of
suspected typhoid cases also had increased antibody titers to B. quintana (139). In a
2005 Marseilles, France study of 930 subjects from two homeless shelters over the course
of four years, 22% were infested with body louse and 5.3% were blood-culture positive
for B. quintana (27). A wide range of seroprevalence rates have also been obtained in
U.S. studies. A 1996 study from Baltimore, MD reported elevated B. quintana antibodies
in 10% of 630 subjects, while a 2001 study of 204 subjects from New York City found
only 2% were seroreactive to B. quintana (39, 40). Yet another study examined 200
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samples obtained from patients at a downtown Los Angeles clinic and reported 9.5%
seroprevalence of antibodies to B. quintana (162). High titers of B. quintana antibodies
were also reported in 11% of 151 blood samples from homeless people in Tokyo, Japan
(158). One study focused solely on immunocompromised individuals and found that
among 382 HIV-positive individuals with a fever of unknown origin, B. quintana or B.
henselae was the cause in 18% of cases. The precise number of fevers attributable to B.
quintana could not be determined due to cross reactivity between the two species in the
assay (97). Again, the differences in reported prevalence of B. quintana undoubtedly
reflect the differences in diagnostic technique, target population, and study design.
Another series of studies has examined the prevalence of B. quintana in body lice. B.
quintana DNA was amplified by polymerase chain reaction (PCR) in 33% of body lice
collected from homeless people in Russia in 1996 and 1997 (150). A recent San
Francisco, CA study amplified B. quintana DNA from 33% of louse-infested individuals
and reported an overall rate of 23.9% body louse infestation in 138 participants.
Interestingly, these authors also amplified B. quintana DNA from head lice obtained in
the same study even though Bartonella is not usually associated with this subspecies of
P. humanus (22, 63). Like seroprevalence rates, a review of a number of these studies
shows wide variation in the percentage of lice infected with B. quintana. For example, B.
quintana was detected in 4-26% of lice from Marseilles, 36% of lice examined in the
Netherlands, 2.3-93.9% of lice examined in Burundi and only 1.4% of lice in Peru (60).
Again, the variability observed in different studies may reflect environmental factors
favoring high rates of infection and transmission.
In addition to urban trench fever and chronic bacteremia, B. quintana and B. henselae
are the primary species responsible for Bartonella-mediated infective endocarditis (IE)
and are thought to account for approximately 1-3% of all infective endocarditis (16, 59).
Similarly, one study indicated that Bartonella species account for more than one-fourth
of blood-culture negative endocarditis cases (BCNE) with B. quintana responsible for 53
of the 70 cases (79). Serological testing for Bartonella has been suggested as a
modification to the original Duke criteria used for the diagnosis of IE (111). Not
surprisingly, epidemiologic analyses indicate that risk factors for B. quintana-mediated
endocarditis include exposure to body lice, alcoholism, and homelessness. This
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investigation also found that patients with Bartonella-mediated endocarditis were at least
twice as likely as controls with endocarditis caused by other organisms to require
valvular surgery and were as likely as controls to have experienced embolic
complications (59). Additional life-threatening complications associated with IE include
congestive heart failure and neurological problems secondary to embolic events (126).
Although isolated reports of the disease in immunocompetent individuals exist,
bacillary angiomatosis is almost entirely associated with immunodeficiences (64, 174).
Characterized by vasoproliferative lesions containing bacilli observable by WarthinStarry staining that can occur in a number of different organs, BA has an estimated
overall prevalence of 1.2 cases per 1000 HIV-positive individuals (121, 133). Although
infection with other Bartonella species can also result in BA, reports suggest that B.
quintana is the causative agent in just under half of the cases examined. Furthermore, B.
quintana, rather than B. henselae, is more likely to be involved in the development of
subcutaneous and bone lesions (65, 96).

F. DIAGNOSIS AND TREATMENT
Given the extraordinary range of clinical manifestations of B. quintana infection
and the fastidious nature of the organism, diagnosis and isolation can both be
challenging. In cases of suspected urban trench fever and chronic bacteremia, diagnosis
is typically made by blood culture and serological testing. Blood culture techniques have
been marginally successful, but basically consist of either direct plating onto solid media
or co-cultivation of the sample with cell culture (57, 88). Even when successful, primary
isolation of Bartonella can take up to two weeks. However, refined protocols specific to
species and tissue sample can enhance Bartonella recovery (57). Numerous serological
tests are available including one that was developed and characterized by the Centers for
Disease Control (CDC). Problems exist with respect to cross reactivity with other
species, including Chlamydia pneumoniae and Coxiella burnetti, a lack of anti-Bartonella
antibody production in up to 25% of blood culture positive HIV-infected individuals, and
slow development of antibodies to Bartonella in some immunocompetent individuals. In
suspected cases of endocarditis and bacillary angiomatosis, additional diagnostic tests
include PCR and histopathological examination of tissue. As previously mentioned, BA
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lesions contain bacilli that can be seen by Warthin-Starry silver staining and clusters of
bacteria are visible in valvular tissue from Bartonella-mediated endocarditis (57, 88).
Various PCR targets have been used to differentiate Bartonella species, including but not
limited to 16S rDNA, the heat shock protein gene htrA, the citrate synthase gene gltA,
and the 16S-23S rDNA intergenic spacer region (ITS) (121).
Although trench fever can be self-limiting, the occurrence of chronic bacteremia in
homeless people has led to the recommendation that the disease should be treated with
200 mg of doxycycline by mouth daily for 28 days combined with a 14-day regimen of
intravenous administration of gentamicin (3 mg/kg body weight). In the case of bacillary
angiomatosis, erythromycin or doxycycline (500 mg 4 times daily or 100 mg twice daily,
respectively) are the drugs of choice and treatment should be maintained for at least 3
months. Treatment recommendations for Bartonella-mediated endocarditis consist of
intravenous administration of gentamicin (3 mg/kg body weight) daily for 14 days (88,
144). Risk factors for B. quintana infection include homelessness, alcoholism and
exposure to body lice. Providing complete clothing changes, boiling infested clothing
and sheets, as well as dusting with insecticides, can be used to counter louse infestation.
Additionally, oral treatment with ivermectin can result in short term decreases in both
number of lice per infested individual and in prevalence of louse infestation (58, 138).
With respect to immunocompromised populations and associated B. quintana-mediated
disease, prophylactic antibiotic treatment is not recommended. Not surprisingly,
prophylactic treatment for other infections with macrolides or rifamycin is also effective
against B. quintana (88).

II. HEMIN

A. HEMIN REQUIREMENTS
The earliest attempts of in vitro cultivation of B. quintana required media
supplemented with erythrocytes. Based on the fact that the red blood cells retained their
growth enhancing properties even after being subject to freeze/thaw cycles or autoclaved,
hemoglobin was suspected as the critical factor provided by them. Examination of B.
quintana growth as a function of hemoglobin concentration in a blood-agar baser
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indicated 4 mg/ml was sufficient provided the medium was also supplemented with
serum (179). Further analyses indicated that the serum requirement could be fulfilled
with bovine serum albumin (BSA), which could in turn be replaced with charcoal or
starch. Under these conditions, either hemoglobin or high concentrations of hemin (2040 µg/ml) were sufficient to support growth. The authors propose a detoxification role
for serum and suggest that hemin may be required for hydrogen peroxide breakdown
(125). In vitro studies in the closely related species, B. henselae, served to further define
the precise components of hemin required for growth of Bartonella. Lactoferrin,
transferrin, and iron, alone or in combination with protoporphyrin IX, were unable to
satisfy the hemin requirement suggesting that hemin itself is the essential component of
erythrocyte lysates for supplying Bartonella with both iron and protoporphyrin IX (152).
These observations were validated by genomic analyses, which indicate that Bartonella
species lack most of the enzymes required to synthesize porphyrins. Ferrochelatase
catalyzes the addition of iron (II) to protoporphyrin IX to generate heme and is among the
missing enzymes (4). The importance of hemin to survival and pathogenesis of
Bartonella is underscored by in vivo studies that indicate mutagenesis of any of a number
of proteins involved in hemin acquisition interferes with the establishment of chronic
intracellular infection of erythrocytes in a rat model (151). Furthermore, Bartonella
species have one of the highest reported hemin requirements amongst bacterial
pathogens. Notably, a similar concentration of hemin is required for growth of some
Haemophilus species that also lack porphyrin biosynthesis pathways (172).

B. HEMIN AVAILABILITY
Heme is a required component of a number of proteins vital to cellular function in
pathogen, vector and host. For example, it is a key component of cytochrome c,
myoglobin, nitric oxide synthase, prostaglandin synthase, and hemoglobin. In fact,
hemoglobin is the most abundant protein in blood and hemoglobin-bound heme
concentrations are approximately 10 mM (68). However, free hemin is toxic in excess
due in part to its hydrophobic nature that allows it to disrupt membrane and cytoskeletal
interactions. Additionally, the iron moiety of heme is able to participate in Fenton
chemistry resulting in the generation of reactive oxygen species (ROS). Accordingly,
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incubation with free hemin can result in protein oxidation leading to cross-linking and
aggregation, lipid peroxidation, single-strand DNA scission or nicking of DNA and
subsequent degradation. Likewise, bloodstream hemoglobin can be oxidized to
methemoglobin by activated inflammatory cells resulting in an enhanced release of
hemin and all of its associated toxicities (11). A number of strategies exist to limit hememediated cytotoxicity. One strategy, employed by bacteria, humans and number of other
organisms, is the breakdown of heme into biliverdin, free iron (Fe 2+) and carbon
monoxide (CO) by heme oxygenases. Another strategy is the production of high-affinity
scavenger proteins such as haptoglobin, which binds hemoglobin, and hemopexin, which
binds heme, thereby neutralizing their ability to cause cellular damage (103). Serum
proteins such as transferrin and lactoferrin are also produced to sequester free iron and
prevent its participation in the generation of damaging reactive oxygen species (103).
Exacerbating the iron and hemin limitation in the human host and underscoring its
importance to the survival and pathogenesis of bacteria is the fact that iron sequestration
is an innate immune response to infection. Mechanisms include decreasing absorption of
dietary iron, increasing serum concentrations of transferrin, increased production of
hemoglobin, haptoglobin and hemopexin, and localized release of lactoferrin by
neutrophils (7, 112). The hemoglobin/hemopexin scavenger receptor, CD163, is released
from the cell surface as a soluble molecule and cell surface expression is subsequently
upregulated in response to lipopolysaccharide- and bacterial flagellin-mediated activation
of Toll-like receptors (185).
In contrast to the human host, little is known about the fate of hemoglobin in the louse
gut during digestion of a blood meal. It is generally accepted that blood-sucking
arthropods face a unique challenge with respect to hemin detoxification as either free or
bound hemin is thought to exceed 5 mM during digestion of a blood meal (68). Although
the mechanisms employed by P. humanus are not known, several adaptations have been
reported in other hematophagous insects. Several reports suggest that certain ticks digest
hemoglobin intracellularly (1, 107). In contrast, some mosquitoes and other insects
sequester heme in the gut lumen by surrounding it with extracellular matrix proteins or
phospholipids membranes. Alternatively, they may surround the gut cells with a
protective matrix (107).
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C. HEMIN UPTAKE SYSTEMS
Utilization of host hemin-containing proteins as a source of both hemin and iron is a
common strategy employed by successful pathogens. In fact, recent studies in
Staphylococcus aureus indicate that hemin is preferred over transferrin as an iron source
(161). Both classical and unique heme uptake systems have been characterized in
several bacterial pathogens. At least two common solutions to the heme uptake problem
exist in Gram-negative bacteria. The first is the use of outer membrane receptors that
directly bind heme or heme-containing proteins (See Fig. 1-1A, p. 19). Heme receptors
are further subclassified on the basis of substrate specificity. For example, the BhuR
receptor of Bordetella avium has been classified in the ‘heme scavenger’ receptor
category based on its ability to use hemin, hemoglobin, myoglobin and catalase while the
HmbR receptor of Neisseria meningitidis is in the more specific hemoglobin subclass
based on its limited ability to obtain heme from other hemoproteins (124, 132).
The second common solution combines the utilization of outer membrane receptors
with secreted high affinity hemophores. Hemophores obtain heme from hemoproteins in
the vicinity and deliver it to the appropriate receptor. A classic example of this solution
is the recently crystallized HasA/HasR system of Serratia marcescens (See Fig. 1-1B, p.
20). Crystallographic data indicate that the transfer of heme from the high affinity
hemophore, HasA, to the lower affinity receptor, HasR, is mediated by a small steric
hinderance upon completion of docking that dislodges the heme from HasA (102).
In either scenario, once heme is bound to the outer membrane receptor it is transported
into the cell by virtue of a periplasmic binding protein and an ATP binding cassette
(ABC) transport system. Heme is slightly larger than the upper threshold size of
molecules able to diffuse across membranes but has been shown to transverse model lipid
bilayers (66). Regardless, heme transport across the outer membrane is energydependent and that energy is obtained from the proton motive force of the inner
membrane through the TonB/ExbB/ExbD complex. TonB is in direct contact with
receptors through its C-terminal domain and its N-terminal domain is in contact with
ExbB and ExbD. The complex is thought to bind protons used to energize TonB through
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conformational changes, which are then transduced to the outer membrane through
interaction with a weakly conserved amino acid consensus sequence found in TonBdependent receptors termed the TonB box (172). TonB-dependent receptors share
structural similarity; they consist of 22 anti-parallel β-strands and share an N-terminal
plug (102). Additionally, heme receptors share a certain amount of amino acid sequence
similarity including conservation of the characteristic FRAP/NPNL domain (183).
The fate of heme upon entering the cytosol is unclear. Most heme uptake loci from
bacterial pathogens include a putative heme degrading/storage enzyme. In some species,
e.g. E. coli O157:H7, these enzymes have been shown to function as heme oxygenases
while homologous proteins in other bacterial pathogens have been described as heme
chaperones or storage molecules (90, 169, 193).
Genomic analyses of B. quintana indicate the presence of at least three systems with
the potential for involvement in heme or iron uptake (4) . One of these is the hut locus,
encoding a potential hemin receptor and a coordinate ABC transporter system (discussed
in detail in Chapter 3). A second locus, designated yfe (A-D), encodes a putative ABC
transporter implicated in manganese, zinc, and possibly ferric iron acquisition, but lacks a
homolog to yfeE. YfeE is an essential component of the system in Yersinia pestis, as
evidenced by its requirement for complementation of an E. coli strain unable to produce
the enterobactin siderophore (15). The final locus, fatB-D, encodes a putative
siderophore transporter system similar to that described in Vibrio species (113). Notably,
B. quintana also encodes a five member family, HbpA-E, of porin-like proteins that have
been shown experimentally to bind hemin despite the absence of structural or sequence
similarity to classical hemin receptors (discussed in detail in Chapter 2) (31, 123).

D. REGULATION OF HEMIN UPTAKE
Like mammalian cells, bacteria are also sensitive to iron- and hemin-mediated
oxidative damage. Therefore, survival of bacterial pathogens requires a balance between
obtaining sufficient iron and heme in the limiting environment of the human host such
that required levels are available and preventing the accumulation of intracellular
concentrations high enough to cause injury. Furthermore, B. quintana must be able to
rapidly shift between the iron-replete louse gut and the iron-deficient human host.
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Numerous examples of iron-responsive transcriptional regulation exist in the literature.
Although homologs exist in many bacterial species, the ferric uptake regulator (Fur) of E.
coli is the most well studied example. Under iron-replete conditions, dimeric Fur binds
ferrous iron (Fe2+), which causes a conformational shift that allows binding to a
consensus sequence (Fur box) and repression of target genes (28). Reports confirming
the role of Fur as a “global” iron responsive regulator are primarily associated with other
members of the γ-proteobacterial subclass. A Fur homolog exists in all pathogenic
Bartonella species, and its role will be discussed in detail in Chapter 2 (131).
In species more closely related to Bartonella, such as Agrobacterium and Rhizobium,
the function of Fur has been largely delegated to novel iron response proteins, namely
the iron response regulator (Irr) and/or the rhizobial iron regulator A (RirA) (71, 148,
190). RirA has primarily been characterized in α-proteobacteria and appears to be an
iron-sulfur cluster regulator (IscR). Mutational analyses suggest that it can function as
either a transcriptional activator or a repressor and target genes include transport systems
involved in hemin and iron acquisition (148, 171, 178). The B. quintana RirA
homologue has 85% amino acid similarity to R. leguminosarum RirA.
Irr is a member of the Fur family, but responds directly to intracellular hemin
concentrations rather than iron and can either transcriptionally activate or repress genes
depending on the location of its cognate DNA consensus motif (71, 149). In
Bradyrhizobium japonicum, Irr is transcriptionally regulated by Fur and posttranslationally regulated by hemin, which rapidly degrades the protein upon binding to it
via two heme response motifs (HRM) (194). In contrast, the Brucella abortus Irr
homolog remains stable even upon heme binding (117). Irr has been shown to repress a
number of genes, including those involved in protoporphyrin biosynthesis under ironlimiting conditions. Positive regulation of both heme and iron uptake systems has been
reported (117, 149). The B. quintana Irr protein has 72% amino acid similarity to B.
japonicum Irr. The precision and speed required for B. quintana to react to shifts in
available hemin as well as the number of systems dedicated to the uptake of this critical
factor suggest a complex regulatory network requiring one or more of the aforementioned
regulators to fine tune uptake and detoxification systems.
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E. IRON/HEMIN-MEDIATED REGULATION OF VIRULENCE
Iron and hemin limitation in the human host serve as environmental triggers for the
expression of virulence factors in many bacterial pathogens. For example, the expression
of Shiga-like toxin (SLT-1), which interferes with eukaryotic ribosomal function, is
repressed by Fur in enterohemorrhagic E. coli strains. Exotoxin A of Pseudomonas
aeruginosa is also under Fur control, albeit indirectly through the Fur-regulated
alternative sigma factor, PvdS (80). A classic example of iron-regulated expression of
virulence factors is the diphtheria toxin from Corynebacterium diptheriae, which is
under control of the DtxR regulator (112). DtxR also controls siderophore biosynthesis
and hemin uptake in Corynebacterium (188). Although the implications are not clear, a
recent study examining lipid A heterogeneity in Porphyromonas gingivalis indicates
increased production of monophosphorylated tetra-acylated and diphosphorylated pentaacylated lipid A when the organism was grown in media containing high (10 µg/ml)
concentrations of hemin compared to the production of only monophosphoryl pentaacylated lipid A when grown in the presence of 1 µg/ml. Of note, lipopolysaccharide
(LPS) containing penta-acylated lipid A has been shown to act as a Toll-like receptor 4
(TLR4) agonist (2). Another recent study examining alterations in gene expression in
response to iron limitation in Bacillus anthracis reported the induction of two putative
internalin genes. Although the function of these genes is not precisely defined, a
homolog in Listeria monocytogenes has been implicated in epithelial cell invasion. The
role of these genes in B. anthracis virulence was established when deletion of either or
both internalin genes resulted in a substantial increase in the number of spores required to
kill half of the mice tested (LD50) (30). These examples indicate that the shift to low iron
and hemin is frequently an indicator of host invasion to pathogens and results in
coordinate control of factors required for virulence.

III. RESEARCH SIGNIFICANCE AND GOALS

A. SIGNIFICANCE
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Hemin is a critical factor for the growth of Bartonella but the mechanisms employed
to obtain it, the regulatory networks controlling those mechanisms and the basis of the
extraordinary requirement remain elusive. Reports describing the Hbp family members
as potential heme receptors combined with identification of a Fur homolog in Bartonella
provided much of the impetus for the current studies (123). The lack of structural
similarity to known heme receptors makes the role of the Hbps in heme acquisition truly
intriguing. Identification of HbpE as one of the predominant proteins recognized by
convalescent sera from patients infected with B. quintana indicates a role virulence and
pathogenesis (23). Bartonella species are currently recognized as emerging agents of a
number of human diseases ranging from self-resolving flu-like diseases to life threatening
endocarditis, but very little is known about mechanisms of pathogenicity. Furthermore,
Hbp homologs exist in several bacterial species, including Brucella and Neisseria (123).
Therefore, any further definition of Hbp function has the potential to be generalized to a
number of important pathogens. Likewise, not only do Bartonella species exhibit an
absolute requirement for heme in order to grow in vitro, one species has been used to
show that both HbpB and several components of the hut locus are required to establish
intracellular infection in vivo (151). Delineation of the roles of the Hbps and the hut
locus proteins is significant because it will either expand or validate the current paradigm
of hemin acquisition in Gram-negative bacterial pathogens. Bacterial hemin acquisition
systems are an attractive target for rational drug design because inhibition of these
systems is likely to be synergistic with the innate immune response and lethal for the
pathogen.
Regulatory networks in Bartonella are largely undefined. Regulation of heme
acquisition is significant in and of itself, but as argued previously many virulence factors
are under transcriptional control of iron-responsive regulators. Given the enormous
differences in heme availability thought to be encountered by B. quintana in the human
host and body louse vector, environmental heme concentrations may serve as an even
more potent cue indicative of the host environment in this species than it is in others.
Iron-responsive regulation in Gram-negative bacteria has primarily been attributed to the
Fur protein owing to the fact that the majority of studies have been done in E. coli.
Identifying Fur targets in Bartonella and examining the activity of the less well known α-
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proteobacterial regulators Irr and RirA will be an important first step in defining the
regulatory network of this hemotrophic bacterium. On a more concrete and practical
level, these studies may begin to characterize inducible species-specific promoters with
potential utility in genetic manipulation.
Finally, the fate of heme upon delivery to the cytoplasm by classical heme uptake
systems is not precisely known. Heme oxygenases (HO) have been identified in
mammalian cells; bacterial HOs have various levels of homology to them (62, 156).
Recent reports suggest that the HemS homolog in E. coli, ChuS, is a unique HO (169).
This is in direct contrast to reports in other bacterial species that suggest that this protein
stores, protects, or transports heme. While these multiple functions are not necessarily
exclusive, no reports of overlapping function exist. The function of this protein is of
particular interest in B. quintana because examination of the genome suggests that this
organism does not possess any sort of iron storage protein, e.g. bacterioferritin (Minnick
and Battisti, unpublished data). Iron acquisition per se has not been described in
Bartonella beyond reports indicating that iron alone is insufficient for in vitro growth
(152). Even if independent iron uptake systems exist, free iron outside of the heme
molecule, or perhaps hemosiderin, is unlikely to be abundant in an erythrocyte. It seems
likely that heme serves as both the porphyrin source and the iron source in B. quintana,
suggesting the necessity of a heme oxygenase. Of additional importance, ChuS is
notably absent from avirulent strains of E. coli and homologous proteins are present in
the genomes of many bacterial pathogens (169). Regardless of the mechanism used by
these proteins to neutralize heme, it undoubtedly contributes to the pathogens' ability to
colonize the mammalian host. Like other components of bacterial heme uptake systems,
ChuS-like enzymes represent an attractive target for the rational design of antimicrobial
peptides in part due to the absence of similarity to mammalian heme oxygenases.

B. RESEARCH GOALS
These studies were undertaken to elucidate the mechanisms and regulation of heme
acquisition in B. quintana. Initial experiments focused on the Hbps and Fur. Based on
descriptions of Fur as a ‘global’ iron-responsive regulator, the first goal was to determine
the function of B. quintana Fur by complementation of an E. coli fur strain. The ability
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of the Hbps to bind hemin and confer a hemin-binding type on E. coli was well
established, but expression profiles in response to alterations in available heme were not
defined. Therefore, the second goal was to examine hemin-mediated regulation of B.
quintana HbpA. The third goal was to examine the effect of B. quintana Fur on hbp
transcription. However, difficulties in identifying natively expressed Fur led to the
modification of this goal such that it became an attempt to identify expression of B.
quintana Fur by either in vitro transcription/ translation (IVTT) or Western blotting. The
HbpA homolog, Pap31, in B. henselae was shown to function as a hemin receptor by
complementation analyses in an E. coli hemA strain (199). The fourth goal was to
examine the ability of HbpA to similarly function as a hemin receptor by
complementation analyses.
The second set of experiments focused on characterizing the function and regulation
of the B. quintana hut locus. The primary goal of this set of experiments was to examine
the ability of HutA to function as a hemin receptor by complementation analysis of the E.
coli hemA strain EB53. Classical heme receptors are typically TonB-dependent. The
ability of HutA to function as a heme receptor in an otherwise isogenic E. coli strain with
a second mutation in tonB was also tested by complementation analyses. A secondary
goal of these studies was to establish heme-mediated transcriptional regulation of the hut
locus and to examine the effects of each of the potential iron-responsive regulators,
namely Fur, Irr, and RirA, on the transcriptional profile of the hut locus genes.
Additionally, these experiments were performed with RNA isolated in parallel from three
different hemin concentrations in order to account for cofactor availability. This was
accomplished by quantitative reverse transcription-polymerase chain reaction (qRTPCR). A third goal was to define the transcriptional organization of the hut locus and this
was accomplished by RT-PCR. The final goal of the experiments was to map the
transcriptional start sites (TSSs) of the transcriptional units in order to identify putative
promoter and regulatory binding sequences.
The final set of experiments undertaken has focused on characterization of the B.
quintana HemS protein. The first goal of these experiments was to generate and purify a
natively-folded His-tagged HemS. The second goal of these experiments was to examine
the ability of the purified recombinant HemS protein to bind hemin. This goal was
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achieved spectrophotometrically and by hemin blotting. The third goal of these studies
was to examine the ability of B. quintana HemS to function as a HO in a
Corynebacterium ulcerans hmuO mutant by complementation. The final goal of these
experiments was to examine the ability of recombinant HemS to catalyze the breakdown
of hemin in vitro. This goal was approached spectrophotometrically.
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Table 1.1. Bartonella species and their ability to cause human disease.
Species
Vector
Reservoir Reference(s)
alsatica
Unknown
Rabbit
(75)
australis
Unknown
Kangaroo
(61)
bacilliformis
Sandfly
Human
(36)
birtlesii
Unknown
Mouse
(18)
bovis
Horn fly (?) Cattle
(17, 38)
capreoli
Tick (?)
Roe Deer
(17, 21)
chomelii
Unknown
Cattle
(114)
clarridgeiae
Flea (?)
Cat
(110, 144)
115) coopersplainsensis Unknown
Rodent
(70)
doshiae
Flea
Rodent
(20, 170)
elizabethae
Flea (?)
Rodent, Dog (49, 50, 116)
130)
grahamii
Flea
Cat
(20, 170)
henselae
Flea, Cat
Cat
(89)
89)
japonica
Unknown
Rodent
(81)
kohlerae
Flea, Cat
Cat
(47, 146)
peromysci
Unknown
Rodent
(20)
phoceensis
Unknown
Rodent
(69)
queenslandensis Unknown
Rodent
(70)
quintana
Body louse Human
(89)
rattaustraliani
Unknown
Rodent
(70)
rattimassiliensis Unknown
Rodent
(69)
rochalimae
Unknown
Human (?)
(53)
schoenbuchensis Deer ked
Deer
(118)
silvatica
Unknown
Rodent
(81)
tamiae
Unknown
Rodents (?) (100)
taylorii
Flea
Rodent
(20, 170)
tribocorum
Flea
Rodent
(76, 141)
talpae
Unknown
Moles
(20)
vinsonii
sub sp. aurepensis Unknown
Rodent
(187)
sub sp. berkhoffi Ticks (?)
Dog, Coyote (34, 77, 99)
sub sp. visonii
Unknown
Vole
(99)
washoensis
Ticks (?)
Dog, Squirrel (34, 37, 101)
weissi
Unknown
Cat
(196)
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Disease Reference(s)
Isolated
(85)
No
Oroya fever (89)
No
No
No
No
Isolated
(98,
No
No
Isolated
(42,
Isolated
Cat Scratch
No
Isolated
No
No
No
Trench fever
No
No
Isolated
No
No
Yes
No
No
No
Isolated
Isolated
No
Isolated
No

(93)
(6,

(9)

(89)

(53)

(100)

(54)
(24)
(134)

A)

Figure 1-1. Schematic of bacterial hemin acquisition systems. A) Model of hemin
acquisition via an outer membrane (OM) hemin receptor and a coordinate transport
system as described in Bordetella (175). BhuR is a hemin receptor that uses energy
transduced by TonB and ExbB/D to bring hemin into the periplasmic space (PS). BhuT
is a periplasmic binding protein that shuttles hemin to the membrane-spanning permease,
BhuU. Energy for hemin transport across the inner membrane (IM) is provided by the
ATPase activity of BhuV. The fate of hemin in the cytoplasm is uncertain. Predicted
functions for BhuS and its homologs include storage or degradation of hemin. B) Model
of hemin acquisition via a hemophore as described in Serratia marcescens (33). The
hemophore HasA is secreted and binds hemin with high affinity. The hemin-HasA
complex docks onto the hemin receptor, HasR, and releases hemin for transport into the
cytoplasm as described in A.
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B)
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CHAPTER TWO
Hemin Uptake Is Not Mediated by Hemin Binding Protein A and the Ferric Uptake
Regulator Is Not Central to Iron-Responsive Regulation in Bartonella quintana

A. INTRODUCTION
Bartonella quintana has an extraordinary heme requirement that is thought to fulfill
both iron and porphyrin needs. B. quintana is expected to have evolved specialized
systems adept at satisfying this requirement despite the heme-limiting nature of the
human host environment. In addition to its success as a human pathogen, B. quintana is
also able to rapidly shift between the human host and the heme-replete gut of the body
louse. Thus, B. quintana must not only be able to acquire heme when it is scarce, but
must also be able to protect itself from heme-mediated toxicities when heme is abundant.
Therefore, the expression of heme uptake systems in B. quintana is expected to be under
tight iron- and/or heme-responsive control. The disparity in heme availability between
these two environments suggests that heme concentration may also serve as an indicator
of the shift into either the human host or the body louse. Consequently it would be
logical to co-regulate heme acquisition and virulence, as described in numerous other
bacterial pathogens. Despite the pivotal role of heme to the survival and pathogenesis of
B. quintana, little is known about either the mechanisms or the regulation of heme
acquisition in this versatile species.
Iron-responsive regulation in Gram-negative bacteria is primarily attributed to the
ferric uptake regulator (Fur) and has been most widely studied in E. coli. In the presence
of excess iron, the dimeric Fur protein binds the ferrous form (Fe2+) and undergoes a
conformational shift. The Fur dimer then binds DNA at a consensus motif,
GATAATGATAATCATTATC, in the promoter region termed the Fur Box and represses
transcription (164). Fur has also been implicated in the activation of genes, but the
mechanisms may involve the regulation of intermediate regulators and/or posttranscriptional control. Fur-targeted genes encode iron and heme uptake systems,
superoxide dismutase, and several virulence factors. In fact, more than 90 genes are
regulated by Fur in E. coli (72). Fur homologues have been identified in several Gram22

negative pathogenic genera including Yersinia, Vibrio, Neisseria, Salmonella and
Haemophilus (143). Although it only has 38% amino acid identity to E. coli Fur, a Fur
homologue was also identified in B. henselae (131). Corresponding fur genes were also
identified in B. bacilliformis and B. quintana (131). Functional analyses of B. henselae
fur indicate that it was able to complement a Vibrio cholerae fur mutant when
constitutively expressed by a ptac promoter (131). Based on these data, we hypothesized
a major role for B. quintana Fur in transcriptional control of heme acquisition systems.
The heme acquisition systems of B. quintana have not been fully characterized, but
studies to date have focused on the genes encoding hemin-binding protein (Hbp) family
members as a potential Fur target. This family consists of five porin-like outer
membrane proteins (HbpA-E) that share ~ 48% amino acid identity to one another and
are able to bind hemin, as implied by the name. Structural predictions suggest that each
Hbp forms a β- barrel consisting of eight conserved transmembrane domains connected
intracellularly by four small loops and extracellularly by four large loops (123). Out of
eight membrane proteins identified by hemin blots, HbpA was chosen for further
investigation because it was the only protein that hemin remained bound to after the blot
was extensively washed (31). Pretreatment of B. quintana with α-HbpA antibody
fractions was sufficient to partially inhibit heme binding relative to controls. Although
recombinant HbpA was unable to confer a hemin-binding phenotype on E. coli, analysis
of a B. quintana hbpA mutant showed increased hemin binding relative to wild type.
Correspondingly, quantitative reverse-transcriptase-PCR (qRT-PCR) examining
expression profiles of the remaining hbp transcripts in the B. quintana hbpA mutant
indicated that compensatory expression occurred with all remaining members of the
family upregulated to some degree. Of note, a sequence was identified in the promoter
region of the hbp genes that shares ~50% identity to the Fur Box of E. coli suggesting a
role for the B. quintana Fur protein in transcriptional control.
HbpA shares amino acid similarity with an outer membrane protein from Brucella,
Omp31, the Opa proteins from Neisseria, and the phage-associated protein, Pap31, from
B. henselae (123). Examination of the hemin-binding capacity of Brucella suis or B. ovis
Omp31 indicates that it also binds hemin. As described with HbpA, pretreatment of B.
ovis with α-Omp31 antibodies inhibits heme binding. Moreover, Omp31 expression is
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increased when B. suis is grown on iron-deficient media relative to the amount produced
when the strain is grown on iron-replete media (43). The hemin-binding capacity of
these proteins is extended in the characterization of Pap31 from B. henselae.
Investigation of this HbpA homolog focused on its ability to function as a hemin receptor
in an E. coli hemA mutant, EB53, which is unable to synthesize porphyrin. As the
parental strain is relatively impermeable to the heme molecule, there are only two ways
for this strain to obtain hemin. The first is to bypass the hemA mutation with the addition
of δ-aminolevulinic acid (the product of the reaction catalyzed by HemA) and the second
is to express a recombinant hemin receptor so that hemin can be imported from an
external source. These experiments indicated that expression of recombinant Pap31,
consisting of the sequence encoding the mature protein fused to the signal sequence from
ompT of E. coli, was sufficient to allow growth of EB53 in the presence of exogenous
hemin (199). Together, these data led to the hypothesis that HbpA functioned as a hemin
receptor in B. quintana, that Hbp expression was responsive to available hemin and/or
iron concentrations, and that this response was mediated at least in part by the Fur
protein.
These studies were undertaken to examine these hypotheses and define the major
mechanisms and regulation of hemin acquisition in B. quintana. Here, we report that
although B. quintana HbpA expression is responsive to available hemin concentration,
expression of the recombinant protein in EB53 is insufficient to reproducibly
complement the hemA strain. Furthermore, while forced B. quintana fur expression is
able to complement an E. coli fur mutant, we were unable to identify an endogenous
promoter in the B. quintana fur gene or express the native protein.

B. MATERIALS AND METHODS

Bacterial strains and growth conditions. E. coli strains were routinely grown
overnight at 37oC with shaking in either Tryptone-yeast extract (TY) and lysogeny broth
(LB) media and standard antibiotic concentrations were added as needed. 25 µM δaminolevulinic acid (ALA) (Research Products International, Prospect, IL) was added to
the medium for growth of E. coli hemA strain EB53 (51). Induction of gene expression
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was achieved with isopropyl-β-D-thiogalactopyranoside (IPTG) at a concentration of 2
mM. B. quintana strains were cultivated on heart infusion blood agar (HIAB) or on
Brucella agar (BA) supplemented with 6 µM to 2.5 mM hemin chloride (Becton
Dickinson, Sparks, MD). Cultures were grown at 37oC in 100% relative humidity and
5% CO2 (12). 10 mg/mL stock solutions of hemin chloride in 0.2 M NaOH were filter
sterilized prior to use. Table 2.1 (p. 34) lists the strains used in this study.

Preparation and manipulation of DNA. All plasmids used or generated in this
study are listed in Table 2.1 (p. 34), and all primers used in this study are listed in Table
2.2 (p. 35). Genomic DNA from B. quintana and E. coli was obtained with a DNeasy
blood and tissue kit (Qiagen, Valencia, CA) per protocol. Plasmids used for restriction
analysis and sequencing were purified with a Perfect Prep plasmid minikit (Eppendorf,
Hamburg, Germany) and those used for electroporation and in vitro
transcription/translation were purified with a Qiagen Midi-Prep kit (Valencia, CA).
Standard procedures were used for ligations, cloning, restriction endonuclease digestion
and analyses, and polymerase chain reaction (PCR) (8). When appropriate, a QIAquick
spin kit was used for purification of PCR amplicons and extraction of DNA from excised
agarose gel slices (Qiagen). Fusion of the mature B. quintana hbpA gene with the E. coli
ompT signal sequence was generated by overlap extension PCR as previously described
(78). The fusion was cloned into the low-copy plasmid pWSK29 (184).

Generation of anti-Fur antisera. A his6-tagged B. quintana Fur protein was
generated and purified under denaturing conditions per QIAexpressionist protocol
(Qiagen). Separation of purified protein fractions was accomplished with sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using 12.5% (wt/vol)
acrylamide. Unfixed gels were washed three times (5 min each) with deionized water
(dH2O), stained with 0.05% Coomassie Brilliant Blue R-250 (Fisher Scientific, Fair
Lawn, N.J.), and destained with dH2O. Purified Fur bands were excised, combined and
used to generate polyclonal anti-Fur antiserum in a female New Zealand White rabbit
(154).
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Hydrogen peroxide treatment of B. quintana. In an effort to upregulate Fur
expression, B. quintana was treated with hydrogen peroxide (H2O2) basically as
described previously (197). Briefly, three plates of mid-log phase B. quintana were
harvested, pelleted (2,300 x g for 10 min at 4oC) then resuspended in 1 ml Brucella broth
supplemented with histidine-hematin (BBH-H50) (50 µg/ml) (35). H2O2 was added to a
final concentration of 50 mM. 200 µl samples were removed at time 0, 10 min, 60 min
and 120 min. Cells were pelleted (15,700 x g for 20 sec at room temperature (RT)),
resuspended in 100 µl sterile dH2O, and placed in a -80oC ethanol bath until needed.

Complementation analyses. Various plasmids containing B. quintana fur were
assayed for functional expression using E. coli fur strain H1780. Strains were plated onto
MacConkey agar supplemented with 100 µM FeCl3 and appropriate antibiotics, then
incubated overnight at 37oC. The ability of B. quintana Fur to repress β-galactosidase
activity was assessed by color: Lac+ Fur- strains produced red colonies and Lac-Fur+
strains produced clear colonies as previously described (73). Complementation assays of
E. coli hemA strain EB53 with B. quintana (ompTSS) hbpA were performed basically as
described (199). In brief, cultures were grown overnight, then pelleted and grown for ~2
hours in TY media lacking δ-aminolevulinic acid to exhaust intracellular porphyrin
stores. Cultures were then used to inoculate TY media alone, supplemented with ALA
(50 µM), or hemin (10 µg/ml or 50 µg/ml) to an initial optical density at 600 nm (OD600)
of 0.02. Growth curves were generated by measuring the OD600 every four hours for 24
hours.

In vitro transcription/translation. The B. quintana fur gene and successively larger
portions of the upstream secA gene were directionally cloned in either the same
orientation or the opposite orientation to the lacZ promoter of either pCR2.1 TOPO or
XL-TOPO in order to map the fur promoter. The E. coli S30 extract system for circular
DNA (Promega, Madison, WI) and a S-35 Express (cysteine-methionine) mix (New
England Nuclear-Dupont, Boston, MA) were used for translation and radiolabeling of the
proteins. Products were separated by SDS-PAGE using 12.5% (wt/vol) acrylamide gels
that were subsequently dried and exposed to X-ray film for up to 96 hours.
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Sarkosyl fractionation, proteinase K treatment, and immunoblotting. Overnight
cultures of E. coli were harvested, washed in phosphate-buffered saline (PBS pH 7.4) and
resuspended in dH2O. Cells were lysed with a FP120 Fast Prep bead homogenizer (45 s
at top speed) using 0.1 mm zirconia beads (Qbiogene, Carlsbad, CA). Cell lysates were
incubated in 2% (wt/vol) N-lauroyl sarcosinate (Sigma, St. Louis, MO) for 30 min and
then centrifuged at 4oC for 60 min at 100,000 x g. The sarkosyl-soluble supernatant was
removed and the insoluble pellet was resuspended in 0.2 mM phenylmethanesulfonyl
fluoride (PMSF) in dH2O.
Surface accessibility of recombinant HbpA was also confirmed by proteinase K
treatment with slight modifications to previously described methods (120). Briefly, cells
were pelleted, washed three times with PBS supplemented with 0.9 mM MgCl2 and 1.0
mM CaCl2 (PBS MgCl2/CaCl2), and enumerated with a LIVE/DEAD BacLight bacterial
viability kit (Invitrogen, Eugene, OR). Live cells were diluted to 109 cells/ml and treated
with 0-1500 µg/ml proteinase K for 10 min at room temperature. The reaction was
stopped by the addition of 200 µg of PMSF in isopropanol. Cells were pelleted and
washed two more times with PBS MgCl2/CaCl2. A bicinchoninic acid kit was used to
determine protein concentrations (Pierce, Rockford, IL). Samples were separated by
SDS-PAGE and resulting gels were transferred to nitrocellulose (GE Water & Process
Technologies, Trevose, PA) for Western blotting (173). Blots were probed overnight
with either rabbit anti-HbpA (1:5000) or anti-Fur (1:500) antiserum and developed with
hydrogen peroxidase-conjugated secondary antibodies (Sigma), 4-chloronapthol, and
hydrogen peroxide. Fur protein expression was also probed with anti-E. coli Fur antisera
(A generous gift from M. Vasil) at a 1:500 dilution for 2 hours, then developed (as
described above).

C. RESULTS

Complementation of E. coli fur strain H1780. The E. coli fur mutant H1780 has a
lacZ fusion under control of the fur promoter that allows iron-mediated control of βgalactosidase production when a functional Fur protein is provided in trans (73). In order
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to test the hypothesis that B. quintana fur encodes a functional ferric uptake regulator, a
construct containing B. quintana fur under control of the plasmid-encoded lac promoter
was generated and used to transform E. coli strain H1780. The resulting strain, along
with a control consisting of H1780 transformed with vector alone, was tested for its
ability to repress β-galactosidase production when grown on iron-rich MacConkey
medium. MacConkey medium contains lactose and a pH indicator such that production
of β-galactosidase results in the generation of lactic acid which makes colonies appear
red, while repression of lacZ results in the generation of whitish-yellow colonies. Results
from these experiments indicate that B. quintana fur is able to repress lacZ in H1780
when grown in the presence of 100 µΜ FeCl3, as evidenced by the production of white
colonies on the left half of the plate in Figure 2-1 (p. 37). Likewise, transformation of
H1780 with pDS1.1 carrying the Brucella abortus fur gene resulted in the generation of
white colonies on iron-rich MacConkey agar (data not shown). In contrast,
transformation of H1780 with vector alone does not complement the fur mutation as
evidenced by the continued production of β-galactosidase resulting in red colonies on the
right-hand side of the plate despite the presence of a high concentration of iron (See
Fig.2-1). These data clearly indicate that the B. quintana Fur protein is a functional ferric
uptake regulator that is able to recognize and bind the E. coli Fur box consensus
sequence.

Synthesis of Fur in E. coli and B. quintana. Initial attempts to identify the Fur
protein utilized polyclonal antisera generated against E. coli Fur. Western blots probed
with this antisera showed reactivity with both uninduced and induced His6-tagged B.
quintana Fur protein expressed in JM109 (Figure 2-2A lanes 1 and 2, respectively, p. 38).
In contrast, although an ~ 50 kDa protein cross-reacts with the anti-E. coli Fur antisera,
there is an absence of reactivity with any protein in the appropriate molecular weight
range in the B. quintana cell lysate (Fig. 2-2A, lane 3). In an effort to provide a more
specific and accurate tool for the detection of B. quintana Fur, we generated anti-B.
quintana Fur antisera using purified recombinant his6-tagged Fur. Immunoblot analyses
indicate strong reactivity to the recombinant B. quintana Fur protein when induced in E.
coli (Fig. 2-2B, lane 2), but no reactivity with any protein in the B. quintana cell lysate
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(Fig. 2-2B, lane 3). Notably, anti-B. quintana Fur antisera also reacts with recombinant
Brucella abortus Fur protein expressed in E. coli (data not shown, Table 2.3, p. 36).
Together, these data suggest that the both antisera recognize conserved Fur antigens but
that the protein is not synthesized in B. quintana under the growth conditions used for
these experiments. In an effort to increase expression of the Fur protein, B. quintana was
treated with hydrogen peroxide for up to 2 hours and then assayed for Fur production by
Western blot. Again, these experiments failed to yield reactivity with the native Fur
protein in B. quintana cell lysates (data not shown).

Mapping the B. quintana fur promoter by in vitro transcription/translation. In
the previous study examining Bartonella henselae Fur, a fusion construct consisting of
the 204 base pairs (bp) fur promoter and the gene encoding green fluorescent protein
(gfp) was used to transform B. quintana and B. henselae. Promoter activity, as evidenced
by the detection of GFP production by flow cytometry, was not detected despite growing
the strains on a range of hemoglobin and iron concentrations (131). These data,
combined with the inability to detect native Fur from B. quintana cell lysates, led us to
examine the potential transcriptional arrangement of this gene. Genomic analyses
indicate that Bartonella fur is separated from its upstream gene, secA, by only 17 bp or
less in B. quintana, B. henselae, and B. bacilliformis (Fig. 2-3A, p. 39) (4). Although it
does not contain the fur gene, secA is transcribed as part of an operon in E. coli (127). In
an effort to locate the promoter region of fur, we generated a series of fur constructs
containing portions of the upstream secA gene and directionally cloned them such that
they were either in the same orientation or flipped with respect to the plasmid-encoded
lac promoter. Examination of the proteins synthesized from these constructs by in vitro
transcription/translation (IVTT) indicates strong expression of the Fur protein when the
fur gene is immediately preceded by the lac promoter (Fig. 2-3B lane 3, p. 39). Faint
expression of the Fur protein is also evident when the entire secA-fur gene fragment is
cloned in the same orientation as the lac promoter (Fig. 2-3B lane 6). In contrast, Fur
expression was not detectable when the fur gene was in the opposite orientation to the lac
promoter (Fig. 2-3B lane 2) regardless of the inclusion of 1600bp of upstream secA
sequence (Fig. 2-3B lane 4) or the entire secA gene (Fig. 2-3B lane 7). Constructs
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containing the entire secA gene produced SecA regardless of orientation (Fig. 2-3B lanes
6 and 7).
IVTT data were corroborated by complementation and Western blot analysis.
Specifically, constructs that produced detectable Fur in vitro also produced Fur in vivo as
evidenced by reactivity with anti-Fur antisera and were able to complement the E. coli
H1780. All of the constructs containing fur in opposite orientation to the lac promoter
failed to produce detectable Fur in vivo and failed to produce functional Fur in the E. coli
fur strain (See Table 2.3). In total, these data imply that although secA contains a
functional promoter, B. quintana fur is not transcribed as part of an operon originating
from secA. In fact, B. quintana fur does not appear to possess a consensus promoter.

Synthesis and localization of B. quintana HbpA in E. coli. Although a role for Fur
in the transcriptional regulation of the hbp genes was not established, the ability of HbpA
to function as a hemin receptor was still of interest. In order to ensure proper trafficking
of B. quintana HbpA in E. coli, Hbp's original signal sequence was replaced with the
signal sequence from OmpT, a known outer membrane protein of E. coli. Outer
membrane localization of the recombinant HbpA fusion in E. coli was subsequently
confirmed by sarkosyl fractionation and immunoblotting. Briefly, selective solubilization
of the bacterial cytoplasmic membrane in 0.5-2% (wt/vol) sarkosyl results in the isolation
of outer membrane proteins (55). The sarkosyl-insoluble protein profile of
pWSKHbpA/EB53 resolved by SDS-PAGE is consistent with that presented in a
previous study of E. coli using the same methodology (See Fig. 2-4A lane 6, p. 40) (48).
A corresponding immunoblot shows the presence of the HbpA fusion in both uninduced
and induced cell lysates from pWSKHbpA/EB53 but absent in EB53 containing only the
vector (Fig. 2-4B, lanes 3, 4, and 2 respectively). Moreover, the immunoblot indicates
that although some HbpA is present in the sarkosyl-soluble fraction (lane 5), the majority
of it resides in the sarkosyl-insoluble pellet (lane 6). These results indicate that the
majority of the B. quintana HbpA fusion protein is properly trafficked to the outer
membrane in E. coli strain EB53.
Outer membrane localization was confirmed by proteinase K treatment of intact cells
to examine the surface accessibility of HbpA in EB53. Immunoblot analyses of cells
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lysates from proteinase K-treated cells indicate a progressive decrease in the amount of
HbpA that directly corresponds to treatment with successively higher concentrations of
proteinase K (See Fig. 2-5B, lanes 2-5, p. 41). Visible changes in HbpA were verified by
densitometry (data not shown). A corresponding silver-stained gel (Fig. 2-5A) served as
a control for protein loading and showed a lack of non-specific protein degradation.
Likewise, a protein slightly larger than HbpA that was cross-reactive with the anti-HbpA
antisera served as an internal control and remained constant despite increasing
concentrations of proteinase K (Fig. 2-5B, lanes 2-5). These results provide strong
evidence for appropriate trafficking of HbpA to the outer membrane of EB53.

Complementation of E. coli strain EB53. In order to examine the ability of B.
quintana HbpA to function as a hemin receptor, complementation analyses of the E. coli
hemA aroB strain EB53 were undertaken. EB53 is a K-12 derivative with a mutation
preventing the generation of δ-aminolevulinic acid (ALA), a key intermediate in the
porphyrin biosynthesis pathway. In the absence of exogenously-supplied ALA, this
strain is unable to exploit hemin as a porphyrin/hemin source due to the relative
impermeability of the membrane to hemin and the absence of a native hemin receptor
(153). However, the severe growth defects resulting from this mutation can be corrected
if a functional hemin receptor is provided. We used this strain to test the hypothesis that
B. quintana hbpA functions as a hemin receptor. In short, overnight cultures of
pWSKHbpA/EB53 and pWSK29/EB53 were incubated for ~2 hours in unsupplemented
media to deplete intracellular porphyrin and ALA stores and were then used to inoculate
TY media alone, or supplemented with ALA or hemin. Growth curves were generated by
measuring OD600 every four hours for 24 hours. As expected, data indicate that both
strains fail to grow in the absence of exogenously-supplied hemin or ALA (Fig. 2-6A, p.
42). When the hemA mutation was bypassed by the addition of 50 µM ALA, both strains
produced normal growth curves (Fig. 2-6B, p. 43). pWSK29/EB53 shows a slightly
higher ‘leak’ rate than pWSKHbpA/EB53 when the strains are grown in media
supplemented with 10 µg/ml hemin (Fig. 2-6C, p. 44). This phenomenon is somewhat
less pronounced when the hemin concentration is increased to 50 µg/ml (Fig. 2-6D, p.
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45). Regardless, the pWSKHbpA/EB53 strain is not able to uptake exogenously-supplied
hemin any faster than EB53 containing the vector alone at either hemin concentration.

D. DISCUSSION

These experiments were undertaken to characterize the mechanisms of hemin
acquisition and its regulation in B. quintana. The first aim of this study was to
characterize the role of Fur in iron-responsive transcriptional regulation. Unexpectedly,
the data presented herein challenge the hypothesis that Fur is the dominant transcriptional
repressor controlling heme and iron uptake in Bartonella. Although the B. quintana fur
gene encodes a functional Fur protein that recognizes the E. coli Fur box, there was no
evidence of a promoter for the gene even when the search was extended to encompass the
entire upstream secA gene and its promoter region. It is tempting to speculate that the
inability to identify an endogenous promoter by IVTT is due to the existence of a B.
quintana-specific sigma factor required for transcription of fur. However, consistent with
the reported inability to detect a promoter in Bartonella using a B. henselae fur-gfp
fusion, we also failed to detect any evidence of native Fur expression in B. quintana by
immunoblotting (131). A notable exception to the inability to detect Fur in Bartonella
occurred when overexpression was forced by transformation of Bartonella with a
construct containing the fur gene in the same orientation as a plasmid-encoded lac
promoter (14). This detail combined with the fact that the antisera reacted well with
Brucella abortus Fur refute any possibility that the inability to detect Fur is due to weak
or nonspecific antisera (data not shown). In contrast, these data collectively suggest that
Fur is not expressed in Bartonella under any of the conditions used in this study.
The absence of Fur expression in Bartonella implies the existence of an alternative
iron-responsive regulator. Consistently, several closely-related α-proteobacterial species
have reported a diminished or nonexistent function for Fur in iron-mediated
transcriptional control despite the almost universal presence of an intact fur gene (86).
In several of these species, the role of Fur has been entrusted to one of two novel
regulators. The first of these is the rhizobial iron regulator, RirA, which resembles the
iron-sulfur cluster regulator of E. coli and has primarily been characterized in Rhizobium
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leguminosarum (171). The other is the iron response regulator, Irr, which has been
primarily characterized in Bradyrhizobium japonicum and is thought to respond directly
to intracellular heme concentrations (195). Genomic analyses revealed that genes
encoding homologs to both of these proteins are present in B. quintana. Of note, the B.
quintana Fur and Irr proteins share ~ 50% amino acid similarity across 91 residues (of
138 possible residues) (Parrow and Minnick, unpublished observation). Therefore, the
focus of our investigation shifted to the role of Irr and RirA in the transcriptional
regulation of the hbp genes. Subsequent studies found that overexpression of either Irr or
RirA in B. quintana resulted in the generation of a bloodstream-like transcriptional hbp
profile, that is, increased transcription of hbpA, D, and E. These data led to the
identification of a conserved consensus sequence in the promoter region of the hbp genes,
designated the H-box, which directly interacts with Irr. In contrast, forced
overexpression of Fur resulted in decreased transcription of only hbpC (14). Based on
previous data suggesting that HbpC may be important in colonization or survival in the
louse gut and the probability that hemin and/or iron are released at toxic levels in this
environment, it is possible that Fur is expressed in B. quintana in response to hemin
concentrations that are toxic in vitro or to an alternative environmental trigger (13).
The second major aim of this study was to examine the ability of B. quintana HbpA to
function as a hemin receptor. Again, the data obtained from this investigation opposed
the original hypothesis. Despite replacing the native signal sequence of B. quintana
HbpA with one certain to be recognized by E. coli followed by confirmation of
appropriate outer membrane localization of recombinant HbpA in E. coli, this protein
failed to complement the porphyrin biosynthesis defect in EB53. While these data are in
direct opposition to a previously-published report indicating that the B. henselae homolog
Pap31 was able to function as a hemin receptor in EB53, it is important to note that the E.
coli hemA strains are somewhat leaky when grown in the presence of hemin (199). This
characteristic increases the likelihood of obtaining a false-positive result, especially if
growth is ascertained “by eye” rather than quantitatively. The absence of any discernable
TonB box in HbpA, as well as both structural and amino acid similarity to known hemin
receptors, are consistent with our data (Parrow and Minnick, unpublished observation).
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Genomic analyses indicate a more probable hemin receptor, HutA, which possesses these
characteristics (discussed in Chapter 3).
Even though HbpA is not a hemin receptor, the strength of the association between the
Hbps and hemin is undeniable. Furthermore, the entire Hbp family is transcriptionally
responsive to fluctuations in hemin concentration (13). Additionally, HbpA can be
specifically retrieved from cell lysates using hemoglobin bound to agarose beads (data
not shown). Collectively, these observations suggest that this interaction is biologically
relevant. The possibility of a function parallel to that established for leghemoglobin in
generating a microaerobic environment for the closely related nitrogen-fixing Rhizobium
and Bradyrhizobium has been suggested (14). However, an oxygen (O2)-labile
nitrogenase is not readily apparent in the B. quintana genome (Parrow and Minnick,
unpublished observation). If the Hbps have a similar function in B. quintana, then the
enzyme requiring protection from oxygen is novel or there is an alternative reason for
excluding O2.
It is tempting to speculate that either the Hbps have an important but indirect role in
hemin acquisition or that the hemin has a role in the adaptation of Bartonella to its
radically different growth environments. Previously suggested possibilities include the
Hbps serving as a surface reservoir for hemin storage or as detoxifying entities via the
intrinsic peroxidase activity of hemin (13). An intriguing alternative to these potential
functions is the possibility that surface heme serves as a sensor via its ability to bind
biologically relevant molecules such as carbon monoxide (CO), nitric oxide (NO), and
oxygen (O2). A similar function for heme has been reported in mammalian cells,
whereby heme binds to and blocks calcium-activated potassium channels but heme bound
to CO releases the channel resulting in its activation (84). Under such a model, the Hbps
would function to transport an unknown molecule across the outer membrane, which
their porin-like structure would facilitate, and heme would serve as a “gatekeeper”. The
opening and closing of the gate would in turn be dictated by the presence of a messenger
molecule. As a starting point for the investigation of this hypothesis, the
spectrophotometric profile of the an Hbp-hemin solution could be compared with the
profile generated by the same solution following addition of CO (84).
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In summary, the data presented herein indicate that HbpA is not able to transport
hemin across the outer membrane when expressed in E. coli. Likewise, our data indicate
that Fur is not a dominant iron-responsive transcriptional repressor because it does not
appear to be expressed under the conditions used in this study. These data are significant
primarily because they indicate the existence of alternative hemin acquisition systems
(discussed in Chapter 3) and transcriptional regulators (14). Furthermore, they indicate a
more subtle role for the Hbps in heme acquisition. Despite the inherent difficulties in
untangling the interaction of the Hbps with hemin, due to the fact that it is absolutely
required for in vitro growth of Bartonella, further studies of this unique family of
proteins are warranted. Elucidation of their function is expected to result in improved
appreciation of Bartonella pathogenesis and host adaptation. Furthermore, the
identification of HbpE as one of the predominant proteins recognized by the human
immune system underscores the importance of these proteins in vivo and may be
exploited as a potential therapeutic target (23).

35

Table 2.1. Bacterial strains and plasmids used in this study

Strain or plasmid
Relevant Characteristic(s)
Bartonella quintana
OK90-268
Human isolate
LS200
OK90-268 cured of pEST
E. coli
DH5α
JM109
H1780
EB53
Plasmid
pCR2.1 TOPO
BqFur TOPO
pNP10
pNP20
pNP30
pQE30
pNP70
pUC 9
pDS1.1
pWSK29
pWSKHbpA
XL-TOPO
pNP40
pNP50
pBBR1MCS
pNP60

Source/Reference
CDC
122

Host strain for cloning
Host strain for expression
MC4100 but fur:: λ placMu53
hemA aroB rpoB

Gibco-BRL
Promega
72
152

TA cloning vector
pCR2.1 TOPO with B. quintana fur insert
pCR2.1 TOPO with B. quintana fur and flanking insert;
same orientation as Plac
As FurB/TOPO but opposite orientation to Plac
pCR2.1TOPO with 1600 bp of B. quintana secA and fur ;
opposite orientation as Plac
Expression vector
pQE30 with B. quintana fur insert
Cloning vector
pUC 9 with Brucella abortus fur insert
Low-copy expression vector
pWSK29 with B. quintana hbpA(ompTSS)
TA cloning vector for long PCR products
XL-TOPO with 3336 bp B. quintana secAfur insert;
same orientation as Plac
As SecAFur 3/ XL-TOPO but opposite orientation to Plac
Broad host range vector
FurB but pBBR1MCS; same orientation as Plac

Invitrogen
130
This study
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This study
This study
Qiagen
This study
Kovach, M.E.
Kovach, M.E.
183
This study
Invitrogen
This study
This study
Kovach, M.E.
This study

Table 2.2 Primers used in this study
Primers
SacI OmpTSS For
OmpTSS Rev
HbpA For
HbpA ApaI Rev
pbbrfur For
pbbrfur Rev
BqfullFur ORF For
BqfullFur ORF Rev
SecA3 For
SecA full ORF For

AGAGCTCTGCAAGCCATTGCGAGGCCT
AGCAATAACATCAGCAGCAAAAGAGCTGATCGCAATAGGGGTTGTCAG
GTCCTGACAACCCCTATTGCGATCAGCTCTTTTGCTGCTGATGTTATTGC
GTGGGCCCACAATCACAAAAATAGAGG
CACCTAGGATGAATAAAAAACGAAATTATGAG
ACGGCGCGCCGTTACTAGTGGATCCGAGCTC
GTAATGAGCGTTGCCCTTGTGG
GTATAAAATTCAATTCGCATGAGG
ATAGGAAACTGTCTGGCATGACGG
GCGCACCAACAAGTATAATGATACC
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Table 2.3. Summary of Fur constructs and experimental results for each.
Abbreviations: C’= complementation data; Ab = Anti-Fur antibody recognition; ND =
not determined.
Strain

Consists of

IVTT C'

Ab

pNP60

B. quintana fur and flanking sequences in pBBR1MCS

ND

yes

yes

pDS1.1

Brucella abortus fur

ND

yes

yes

pNP10

pNP60 but pCR2.1TOPO; same orientation as Plac

yes

yes

yes

pNP20

pNP10 but opposite orientation as Plac

no

no

no

pNP30

1600bp of B. quintana secA and fur;
in opposite orientation to Plac

no

no

no

pNP40

3336 bp B. quintana secA-fur insert;
same orientation as Plac

faint

partial faintly

pNP50

pNP40 but opposite orientation to Plac

no

no

yes

partial yes

ND

no

BQ Fur 2/ Topo B. quintana fur insert in pCR2.1TOPO

pNP70

B. quintana fur insert in pQE30
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no

yes

A)

B)

Figure 2-1. Complementation of E. coli fur mutant H1780 with B. quintana fur.
Overnight growth of H1780 containing A) pNP60 and B) pBBR1MCS on iron-rich
MacConkey agar. B-galactosidase activity is evident by the production of red colonies in
B), while its repression is indicated by the production of whitish-yellow colonies in A).
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A)

B)

Figure 2-2. Analysis of Fur expression by immunoblotting. Western blot of cell
lysates from uninduced JM109/pNP70 (lane 1), induced JM109/pNP70 (lane 2), and B.
quintana strain LS200 (lane 3) probed with A) anti-Fur antiserum generated with E .coli
Fur or B) anti-Fur antiserum generated with B. quintana Fur. The recombinant His6tagged Fur protein is evident in the induced samples when blots are probed with either
antiserum. Although cross reactive proteins are present when probed with the E. coli
antisera, Fur is not apparent in the B. quintana lysate in either blot.
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A)

B)

Figure 2-3. Absence of an endogenous fur promoter by in vitro transcription/
translation. A) Schematic showing the genomic arrangement of the secA and fur genes
in B. quintana and the relative sizes of the various constructs used in IVTT. B) IVTT
analysis of constructs containing B. quintana fur containing portions of the upstream
secA gene in the same or opposite orientation to the plasmid-encoded lac promoter.
Lanes: 1, pCR2.1 TOPO; 2, pNP20; 3, pNP10; 4, pNP30; 5, XL-TOPO; 6, pNP40; 7,
pNP50. A Fur product is evident in lane 3 and faintly visible in lane 6. Molecular mass
standards are given on the left in kilodaltons.
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A)

B)

Figure 2-4. Outer membrane localization of HbpA in E. coli strain EB53 by
sarkosyl fractionation. Lanes: 1, Molecular mass standards; 2, pWSK29/EB53; 3,
pWSKHbpA/EB53 (uninduced); 4, pWSKHbpA/EB53 (induced); 5, pWSKHbpA/EB53
sarkosyl-soluble fraction; 6, pWSKHbpA sarkosyl-insoluble fraction. A) Coomassie
blue stained SDS-PAGE gel. B) Corresponding immunoblot developed with anti-HbpA
showing HbpA is present in uninduced and induced cell lysates, as well as both sarkosyl
fractions. The majority of the HbpA is in the outer membrane. Molecular mass
standards are indicated on the left in kilodaltons.
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A)

B)

Figure 2-5. Surface accessibility of HbpA in E. coli strain EB53 by proteinase K
digestion. A) Silver stained SDS-PAGE gel of proteinase K-treated pWSKHbpA/EB53.
Lanes: 1, 0µg/ml PK; 2, 100µg/ml PK; 3, 500µg/ml PK; 4, 1000µg/ml PK; 5, 1500µg/ml
PK. B) Corresponding immunoblot probed with anti-HbpA indicates surface
accessibility as evidenced by dose-dependent proteinase K sensitivity.
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A)

Figure 2-6. Complementation of E. coli hemA strain with B. quintana hbpA. 24 hour
growth curves of E. coli EB53 containing vector alone (pWSK29) or pWSKHbpA
inoculated into TY media: A) containing neither ALA nor hemin B) supplemented with
50µM ALA C) supplemented with 10µg/ml hemin or D) supplemented with 50µg/ml
hemin.
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B)
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C)
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D)
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CHAPTER THREE
Function, Regulation, and Transcriptional Organization of the Hemin Utilization
Locus of Bartonella quintana
Nermi L. Parrow, Jasmin Abbott, Amanda R. Lockwood, James M. Battisti, and Michael
F. Minnick. 2009. Infect. Immun. 77(1): 307-316

A. ABSTRACT

Bartonella quintana is a Gram-negative agent of trench fever, chronic bacteremia,
endocarditis, and bacillary angiomatosis in humans. B. quintana has the highest known
hemin requirement among bacteria, but the mechanisms of hemin acquisition are poorly
defined. Genomic analyses revealed a potential locus dedicated to hemin utilization (hut)
encoding a putative hemin receptor, HutA, a TonB-like energy transducer, an ABC
transport system comprised of three proteins, HutB, HutC, and HmuV, and a hemin
degradation/storage enzyme, HemS. Complementation analyses with E. coli hemA show
that HutA functions as a hemin receptor and in E. coli hemA tonB indicate that HutA is
TonB-dependent. Quantitative reverse transcription polymerase chain reaction (qRTPCR) analyses show that hut locus transcription is subject to hemin-responsive
regulation, which is primarily mediated by the iron response regulator (Irr). Irr functions
as a transcriptional repressor of the hut locus at all hemin concentrations tested.
Overexpression of ferric uptake regulator (fur) represses transcription of tonB in the
presence of excess hemin, whereas overexpression of the rhizobial iron regulator (rirA)
has no effect on hut locus transcription. RT-PCR analyses show that hutA and tonB are
divergently transcribed, and remaining hut genes are expressed as a polycistronic mRNA.
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Examination of the promoter regions of hutA/tonB and hemS indicates homology to
consensus sequence promoters and encompasses an H-box element previously shown to
interact with B. quintana Irr.

B. INTRODUCTION

Bartonella quintana, the Gram-negative bacterial agent of epidemic trench fever
during World Wars I and II, is one of several Bartonella species of current medical
relevance (27). B. quintana is transmitted to humans via the human body louse
(Pediculus humanus corporis) and is re-emerging in large metropolitan areas amongst
destitute individuals as ‘urban trench fever’. Risk factors for urban trench fever include
alcoholism, homelessness, and exposure to body lice (33). Unlike classical trench fever,
a self-limiting flu-like disease, the re-emerging disease is associated with chronic
bacteremia and endocarditis regardless of immune status (33). B. quintana infection can
also result in bacillary angiomatosis (BA); which is the development of proliferative
vascularized lesions of the skin (43). Although BA primarily affects patients infected
with human immunodeficiency virus (HIV) or other immunodeficiencies, a limited
number of cases have been reported in immunocompetent individuals (46).
HIV infects approximately 0.47% of the general U.S. adult population and there are an
estimated 800,000 homeless people in the U.S. on any given day (26,38). Some studies
suggest that HIV prevalence is up to five times higher in homeless populations than in the
general population (1). Despite the relatively large population at risk for B. quintana
infection, trench fever is recognized as a “neglected infection of poverty” (19).
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Accordingly, insufficient data exist for a general estimate of prevalence in the U. S. and
very little is known about the pathogenesis of this bacterium.
Utilization of host heme-containing proteins as a source of iron is a common strategy
for bacterial pathogens (16). In addition to using these heme or hemin (the Fe3+ oxidation
product of heme) sources, Bartonella species are unique in their ability to parasitize
human erythrocytes (27,37). In the absence of erythrocyte lysates or hemoglobin, in vitro
growth of B. quintana requires media supplemented with the highest known
concentrations of hemin among bacterial species (31). Free heme is toxic in humans due
to its lipophilic nature and ability to participate in the generation of reactive oxygen
species via Fenton chemistry. Therefore, it is either rapidly catabolized by a heme
oxygenase system or neutralized by one of several host heme-binding proteins,
maintaining a very low concentration (22). However, complexed heme, primarily
hemoglobin, is abundant (16). Acquisition of heme in the limiting environment of the
human host is pivotal to the survival and pathogenesis of B. quintana. In contrast to the
human host, free heme is thought to exceed toxic levels in the gut of blood-sucking
arthropods during the initial digestion of a blood meal (34). The ability of B. quintana to
withstand the heme-limiting environment of the human host and the heme-replete gut of
the body louse suggests that its heme acquisition systems are tightly regulated.
Little is known about molecular mechanisms or regulation of heme acquisition by
Bartonella. Previous studies by our lab focused on the hemin-binding proteins (HbpAE), a five-member family of outer membrane porin-like proteins (28). In addition to
binding hemin, Hbps are transcriptionally regulated in response to variations in ambient
temperature, oxygen levels, and hemin concentration (5). This regulation is mediated in
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part by Irr (iron response regulator), a member of the ferric uptake regulator (Fur)
superfamily first described in Bradyrhizobium japonicum, that responds directly to hemin
(17). Irr acts as either a transcriptional activator or repressor by binding the iron control
element (ICE) of B. japonicum, and the effect of Irr on target genes is believed to be a
consequence of ICE’s location relative to the transcriptional start site (39). In B.
quintana, Irr operates by binding a unique DNA motif found in the promoter region of all
hbp genes, termed “H-box” (6). B. quintana has at least two additional iron- and/or
hemin-responsive regulators, namely Fur and RirA (rhizobial iron regulator A) (2). In γproteobacteria, Fur functions as a transcriptional regulator of iron and hemin uptake
systems with activation dependent on intracellular iron concentrations (18). In contrast,
Fur has been shown to play a diminished or nonexistent role in α-proteobacteria (20). fur
overexpression in B. quintana resulted in decreased hbpC transcription but had no effect
on other hbp genes (6). RirA has primarily been studied in Rhizobium leguminosarum
and is homologous to the iron-sulfur cluster regulator (IscR) of E. coli (48).
Overexpression of rirA in B. quintana resulted in increased expression of hbpA, hbpD,
and hbpE (6).
Hbps lack amino acid sequence similarity and predicted structural similarity to known
bacterial hemin receptors, despite their ability to bind hemin and regulation by heminresponsive transcription factors (10). Therefore, we hypothesized that an alternate hemin
uptake and utilization locus was present in B. quintana and identified a candidate through
analysis of the available genome (2). The current study was undertaken to characterize
the function, regulation, and transcriptional organization of this locus.
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C. MATERIALS AND METHODS

Bacterial strains and growth conditions. E. coli was routinely grown overnight at
37oC in Luria-Bertani (LB) or tryptone-yeast extract (TY) media with standard antibiotic
concentrations when required. For induction of gene expression, IPTG (isopropyl-β-Dthiogalactopyranoside) was added to mid-log cultures at a final concentration of 2mM
and cultures were grown for an additional 4-5 h. For growth of E. coli hemA strains
EB53 and IR754, media were supplemented with 25µM δ-aminolevulinic acid (ALA)
(Research Products International , Prospect, IL) (12). B. quintana strains were grown on
chocolate agar or on Brucella agar (BA) (Becton Dickinson, Sparks, MD) supplemented
hemin chloride (CalBiochem, San Diego, CA) at 37oC in 5% CO2 and 100% relative
humidity. 10mg/ml hemin chloride was dissolved in 0.2M NaOH and filter sterilized for
a stock solution. In order to maintain pBBR1MCS and derivatives in B. quintana,
medium was supplemented with 1µg/ml chloramphenicol. B. quintana plates were
harvested at mid-log phase [3-5d post-inoculation (6)] and age-matched for individual
experiments. Strains used in this study are summarized in Table 3.1 (p. 65).

In silico analyses. Genomic sequences for B. quintana strain Toulouse were accessed
at the RhizoDB website (http://xbase.bham.ac.uk/rhizodb/) (11) or the National Center for
Biotechnology Information website (http://www.ncbi.nlm.nih.gov). BLAST was
employed for all database searches (3) and ClustalW version 2.0 (23) was used for
multiple amino acid sequence alignments. The Protein Homology / Analogy Recognition
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Engine (Phyre) program (9) was used to predict three-dimensional protein structures
(http://www.sbg.bio.ic.ac.uk/phyre/).

Preparation and manipulation of nucleic acids. B. quintana genomic DNA was
purified with a DNeasy Blood and Tissue kit (Qiagen, Valencia, CA). Plasmids were
purified with a QIAprep Spin Miniprep kit (Qiagen), Perfectprep Plasmid Mini kit
(Eppendorf, Hamburg, Germany), or Wizard Plus Midiprep DNA Purification System
(Promega, Madison, WI). Routine procedures were employed for PCR amplification,
ligation, cloning and restriction endonuclease digestion (4). PCR and sequencing primers
were synthesized by Operon Biotechnologies (Huntsville, AL).
Total RNA was isolated from B. quintana immediately upon harvest with a RiboRureBacteria Kit (Ambion, Austin, TX) per protocol except cell lysis was done with an FP120
Fast Prep bead homogenizer (45 sec at top speed) using Zirconia beads supplied
(Qbiogene, Carlsbad, CA). DNase treatment was accomplished with a Turbo DNA-free
kit (Ambion). Nucleic acids were quantified using a Spectronic Genesys 2 (Milton Roy,
Rochester, NY) or a NanoDrop ND-1000 (Thermo Fisher Scientific, Waltham, MA)
spectrophotometer. Based on published sequence (2), primers for qRT-PCR were
synthesized by Integrated DNA Technologies (Coralville, IA) and are listed in
Supplementary Table 3.1 (p. 65).

Complementation assays. The ability of E. coli hemA strains EB53 or IR754
(containing pNP1 or vector alone) to use hemin was examined as previously described
with modifications (47). Briefly, overnight cultures were centrifuged at 3900 x g for 5
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min at 4oC and pellets were resuspended in 5ml TY without ALA. Cultures were
incubated ~2 h at 37oC with shaking to deplete intracellular ALA and hemin and then
used to inoculate 8ml cultures of TY alone or supplemented with either ALA (50µM) or
hemin chloride (10µg/ml or 50µg/ml) to an initial optical density of 0.02 at 600 nm
(OD600). Cultures were incubated at 37oC with agitation and OD600 was measured every
4 h for 24 h.

Generation of anti-HutA antisera. A 6xHis-tagged mature B. quintana HutA
protein was generated and purified under denaturing conditions using the QIAexpress kit
(Qiagen). Purified protein fractions were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and 12.5% (wt/vol) acrylamide gels (4).
Gels were rinsed three times for 5 min in deionized water and then stained with 0.05%
(wt/vol) Coomassie blue in deionized water for ~30 min. Following destaining in water,
the purified HutA band was excised and used to generate rabbit anti-HutA antiserum as
previously described (42).

Sarkosyl fractionation and immunoblotting. Proteins were quantified by a
bicinchoninic acid protein kit (Pierce, Rockford, IL). Sarkosyl fractionation was
performed essentially as previously described (52). Briefly, overnight cultures of E. coli
were harvested, washed in phosphate-buffered saline (pH 7.4), and resuspended in sterile
distilled H2O. Cell lysis was done with a Fastprep bead homogenizer as above. Cells
were incubated for 30 min in 2% (vol/vol) N-lauroyl sarcosinate (Sigma, St. Louis, MO)
at room temperature and then centrifuged for 1 h at 100,000 x g at 4oC in a SW60Ti rotor
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(Beckman Coulter, Fullerton, CA). The sarkosyl-insoluble pellet was resuspended in
0.2mM phenylmethylsulfonyl fluoride (PMSF) in deionized water (Sigma). Both the
resuspended pellet and sarkosyl-soluble supernatant fraction were stored at -20oC until
needed. Samples were resolved by SDS-PAGE and transferred to supported
nitrocellulose (GE Water & Process Technologies, Trevose, PA) for immunoblotting
(49). Resulting blots were probed overnight with rabbit anti-HutA antiserum and
developed with horseradish peroxidase-conjugated goat anti-rabbit antibodies (Sigma), 4chloronaphthol, and hydrogen peroxide, as previously described (42).

qRT-PCR and RT-PCR. Relative differences in hut locus expression were
quantified in B. quintana grown on BA supplemented with low (0.05mM) or high
(2.5mM) hemin relative to an optimal hemin concentration (0.15mM) or for JK31
overexpressing fur, irr, or rirA relative to JK31 with pBBR1MCS vector alone (6). For
each condition, 500ng RNA was reverse transcribed per manufacturer’s instructions with
iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). 0.67 ng template cDNA and
500nM of each primer were used per 25µl reaction with iQ SYBR Green Supermix (BioRad) as recommended. qRT-PCR reactions were incubated for 5 min at 95oC, then 40
cycles at 95oC for 30 sec followed by 55oC for 30 sec. Data were obtained with a MyIQ
Real-Time PCR detection system and Optical System software version 1.0 (Bio-Rad).
Mean values from each triplicate reaction were used to determine individual fold
differences in gene expression by the 2-∆∆Ct method using 16S rRNA as the internal
control (24).
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Transcriptional organization of the hut locus genes was examined by reverse
transcribing the hmuV transcript and using it for PCR amplification of individual hut
genes as previously described (29). Briefly, 500-1100ng DNase-treated RNA from JK31
grown on BA containing 0.05mM hemin was reverse transcribed using SuperScript III
First Strand Synthesis for RT-PCR (Invitrogen) per protocol. Resulting cDNA was used
as a PCR template with primer sets for hemS, hutA, hutB, hutC and hmuV. A reaction
lacking reverse transcriptase was used as a PCR template to control for contaminating
DNA.

Transcriptional start site (TSS) mapping. RNA was isolated from B. quintana
grown on BA supplemented with 0.05 or 0.15mM hemin and used for TSS mapping of
tonB, hutA, and hemS with a 5’ RACE system for Rapid Amplification of cDNA Ends,
version 2.0 (Invitrogen, Carlsbad, CA). Briefly, RNA was reverse transcribed with
Superscript II and the resulting cDNA was RNase treated. Following purification of
cDNA with a QIAquick PCR purification kit (Qiagen), a 3’ dC tail was added, and tailed
cDNA was PCR amplified with the Abridged Anchor Primer (AAP) supplied in the
5’RACE kit and a nested, gene-specific primer. PCR products were cloned into pCR2.1TOPO and used to transform E. coli TOP10F’ per TOPO TA Cloning (Invitrogen)
protocol. Plasmids were screened for appropriately sized inserts and sequenced.

DNA sequencing. Sequence data were obtained with an automated DNA sequencer
(AB3130x1 Genetic Analyzer) and a BigDye Terminator Cycle Sequencing Ready
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Reaction kit 3.1 (ABI, Foster City, CA). Sequence data were analyzed with ChromasPro
1.13 (http://www.technelysium.com.au/ChromasPro.html).

Statistical analyses. Three independent determinations were used to calculate the
mean and standard deviations for all numerical data. Statistical significance was
determined using the Student’s t test with P values < 0.05 considered significant.

D. RESULTS
In silico analyses of B. quintana hut locus. The hut locus consists of six genes
encoding a potential receptor, HutA, an ABC transport system, HutBC and HmuV, a
TonB orthologue, and a hemin storage/degradation enzyme, HemS (Fig. 3-1A, p. 66).
The gene arrangement suggested the possibility for divergent transcription of tonB and
hutA (8), while hemS, hutBC and hmuV appeared polycistronic due to close linkage.
BLAST analyses indicated that orthologues exist for each member of the hut locus in
other α-proteobacteria (Fig. 3-1A). Of note, B. quintana TonB lacks an N-terminal
domain that facilitates ExbB-ExbD (cytosolic membrane proteins used in energy
transduction) contact and cytoplasmic anchorage in E. coli (35). Similarly, the predicted
TonB box of B. quintana HutA shares only ~50% conservation with the consensus
sequence of TonB-dependent proteins (data not shown) (30). ClustalW alignment of
HutA with hemin/hemoglobin receptors of other pathogenic bacteria shows conservation
of characteristic FRAP and NPNL domains (10) (Fig. 3-1B, p. 67). A conserved
histidine (HIS 461) essential for hemin utilization by Yersinia enterocolitica HemR has
been replaced by a tyrosine (TYR 505) in B. quintana HutA (10) (Fig. 3-1B). This
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substitution is also seen in BhuR, the Bordetella avium heme/hemoprotein receptor (30).
Like BhuR, HutA shares more homology with the “heme scavenger” subclass of
receptors than with the hemoglobin subclass (e.g., HmbR of Neisseria meningitides) (45).
Three dimensional modeling of B. quintana HutA shows structural similarity to the ferric
citrate receptor (FecA) of E. coli (14), where threading revealed the expected twenty-two
antiparallel β-strands and 11 extracellular loops characteristic of TonB-dependent
receptors (data not shown) (13). TYR 505 was centrally positioned in one of the
extracellular loops of the protein, as were four additional tyrosines (i.e., residues 278,
451, 511, and 512) and histidine 389 (9). In silico data strongly suggest the hut locus is a
system dedicated to hemin acquisition and that HutA functions as the receptor.

Complementation of E. coli hemA strains. The outer membrane of E. coli K12 is
impermeable to hemin, and growth defects from mutations in porphyrin biosynthesis
genes cannot be overcome with hemin supplements (41). E. coli hemA aroB strain EB53
is a K12 derivative with a mutation in glutamyl-tRNA reductase, required for
biosynthesis of ALA and ultimately protoporphyrin IX (7). Exogenously supplied ALA
can restore growth of EB53, however, utilization of hemin requires a functional hemin
receptor (44). To test the hypothesis that B. quintana HutA functions as a hemin
receptor, hutA was cloned into pWSK29 to produce pNP1 and used to transform EB53.
When grown in the absence of ALA and hemin, EB53/pWSK29 and EB53/pNP1
exhibited the characteristic “leaky” growth (maximum OD600 of ~ 0.185 in 24 h; data not
shown) previously noted in these strains (41). Normal growth curves were obtained for
both EB53/pWSK29 and EB53/pNP1 when TY broth was supplemented with 0.05mM

58

ALA (data not shown). However, when media were supplemented with 10µg/ml hemin,
EB53/pNP1 grew to a significantly higher OD600 by 24 h (p<0.029) than EB53/pWSK29
(Fig. 3-2A, p. 68). This difference was more pronounced when strains were grown in
media supplemented with 50µg/ml hemin (p<0.0002) (Fig. 3-2B). Interestingly, rescue
of the hemA mutation in E. coli by B. quintana HutA is not apparent until ~16 h postinoculation despite hemin/ALA starvation. Regardless, these data indicate that B.
quintana HutA functions as a hemin receptor, and its expression in EB53 is sufficient to
allow utilization of hemin as a porphyrin source.
In order to examine HutA’s potential dependence on TonB for energization, pNP1 was
also used to transform E. coli strain IR754 (47). As observed in the EB53 strains, both
IR754/pWSK29 and IR754/pNP1 exhibited normal growth curves in TY media
supplemented with 0.05mM ALA and neither strain surpassed the basal “leaky” growth
level in media lacking both ALA and hemin (data not shown). However, expression of B.
quintana HutA could not restore growth of IR754 in media supplemented with either
10µg/ml or 50µg/ml hemin (Figs. 3-2A and 3-2B, respectively) in direct contrast to
EB53. These data clearly indicate that HutA-mediated hemin uptake is dependent on E.
coli TonB.

Synthesis of HutA in B. quintana and E. coli. We were able to identify native HutA in
B. quintana and recombinant His-tagged HutA in E. coli strain JM109/pNP3 (data not
shown), but were unable to detect HutA in E. coli strain EB53/pNP1 by Coomassie blue
staining or Western blotting. However, expression and induction of hutA mRNA in E.
coli strain EB53/pNP1 were detectable by qRT-PCR. As expected, cDNA from
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EB53/pWSK29 gave results similar to those obtained from a no-template control (data
not shown). Recombinant HutA protein is undoubtedly localized to the outer membrane
of EB53/pNP1 as deduced from its ability to rescue the hemA mutation and restore
growth in the presence of hemin. Failure to detect HutA in EB53/pNP1 is possibly due to
a combination of low level expression and antiserum cross-reactivity. A similar situation
was reported for detection of the recombinant B. henselae orthologue (Pap31) in E. coli
strain M15 until a monoclonal antibody was employed (52).

Transcription of hut locus genes is hemin-responsive. hut locus genes were expected
to be tightly regulated in response to available hemin. To investigate this hypothesis,
RNA was isolated from B. quintana grown on media supplemented with low (0.05mΜ),
optimal (0.15mM), and high (2.5mM) concentrations of hemin and used to examine
differences in hut levels by quantitative reverse transcriptase-polymerase chain reaction
(qRT-PCR). Data show that expression of hut locus genes from JK31 grown on BA0.05mM hemin is only ~1.5-fold higher than that obtained from JK31 grown on BA0.15mM hemin, suggesting that this range of hemin concentrations does not substantially
alter expression of the hut locus. The most pronounced change was observed when
transcript levels from JK31 grown on BA-2.5mM hemin were compared to those from
JK31 grown on BA-0.15mM, where results show an ~2.2-fold decrease in transcription
of hut locus genes in response to excess hemin (Fig. 3-3, p. 69). Furthermore, the hut
locus genes are coordinately regulated as evidenced by the fact that fold differences for
each hut locus gene are repressed to approximately the same magnitude. These results
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show that hut locus genes are transcriptionally down-regulated in response to excess
hemin.

Hemin-responsive control is mediated by B. quintana Irr. To elucidate regulation of
hut locus genes, JK31 strains that overexpress one of three iron/hemin-responsive
regulator genes were used for qRT-PCR experiments to investigate the effects on
transcription. RNA was isolated from overexpression and vector-only strains grown in
parallel on BA-0.05mM hemin, BA-0.15mM hemin, and BA-2.5mM hemin to control for
cofactor availability. Average fold differences between JK31+pBBR-RIRA and
JK31+pBBR indicate a 7 to 16-fold increase in rirA transcription but less than a 1.8-fold
increase in transcription of any hut locus gene under optimal or hemin-limiting growth
conditions. Likewise, overexpression of rirA results in less than a 1.8-fold decrease in
transcription of any hut locus gene when RNA is isolated from strains grown in the
presence of excess hemin (Fig. 3-4A, p. 70). These data suggest that rirA overexpression
does not appreciably affect transcription of hut locus genes regardless of ambient hemin
concentration.
Similar results were obtained when hut locus transcript levels were compared in
JK31+pBBR-FUR relative to JK31+pBBR after growth on BA-0.05mM hemin. These
conditions resulted in less than a 1.7-fold increase in any hut locus gene, while fur
overexpression was evident by a 4.4-fold increase (Fig. 3-4B, p. 71). On BA-0.15mM
hemin, fur transcription was increased ~8-fold in JK31+pBBR-FUR relative to
JK31+pBBR, hemS levels were almost identical, and the remainder of the hut locus genes
showed a minor decrease in transcription. fur overexpression results in a 2.5-fold
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increase in fur and a 4-fold decrease in tonB, when comparing hut locus expression from
strains grown in the presence of excess hemin,. The remainder of the hut locus shows
only a minor decrease in expression as seen in strains grown with optimal hemin
concentrations. These data suggest that fur overexpression in the presence of excess
hemin exerts a repressive effect on tonB that is not imposed on other members of the hut
locus.
irr overexpression results in decreased transcription of the entire hut locus (Fig. 3-4C,
p. 72). Average fold differences in transcription of hut locus genes from JK31+pBBRIRR relative to JK31+pBBR resulted in a 7 to 12-fold increase in irr mRNA and an ~2.5
fold decrease in transcription of all hut genes regardless of hemin concentration.
Interestingly, the decrease in transcription during irr overexpression is similar in
magnitude to the decrease in hut locus expression in the presence of excess hemin (Fig.
3-3, p. 69).

These data suggest that hemin-responsive regulation of hut genes is

mediated, at least in part, by Irr.

Transcriptional organization of the hut locus. Genomic arrangement of the hut locus
suggested that hutA and tonB might be divergently transcribed, while hemS, hutBC, and
hmuV could be polycistronic (Fig. 3-1A, p. 66). To test these hypotheses, RNA from
JK31 was reverse transcribed with a hmuV primer. PCR analyses were performed on the
resulting cDNA using primers specific to each member of the hut locus (except tonB) and
a separate PCR reaction using genomic DNA template was used as a positive control for
each gene. Data indicate that hemS, hutB, hutC, and hmuV are all present in the hmuV
transcript as evidenced by the PCR amplicons generated with primers specific to each of
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these genes from the hmuV cDNA. In contrast, no hutA amplicon is generated from the
cDNA (Fig. 3-5, p. 73). Furthermore, no PCR amplicons were generated from the
reactions using the sample that was not reverse transcribed, which confirms the absence
of contaminating DNA. These data show that hemS, hutB, hutC, and hmuV are cotranscribed as part of a polycistronic transcript from the hemS promoter, while hutA is
transcribed as a separate mRNA.

TSS mapping and identification of “H-box” elements. To further elucidate regulation
of the hut locus, TSS’s were mapped for tonB, hutA, and hemS by 5’ RACE. The hutA
TSS was found 121 bp upstream of its start codon, and the tonB TSS was mapped 40 bp
upstream of its start codon. Putative -10 and -35 sites were identified in the 78-bp
divergent promoter region (Fig. 3-6A, p. 74). Examination of the divergent promoter
region between tonB and hutA showed ~69% identity with a 40-bp consensus sequence,
previously identified in Bartonella hbp promoter regions (6). The H-box completely
encompasses the -10 and -35 sites of hutA and is located 1 bp before the potential -35 site
of tonB. In contrast, no obvious similarity to the Fur-binding motifs of E. coli or B.
japonicum Fur proteins was found upstream of tonB (15).
The hemS TSS was mapped 70 bp upstream of the start codon and potential -10 and 35 sites were identified relative to the TSS (Fig. 3-6B, p. 75). The hemS promoter region
also contains a site with ~57% identity to the H-box consensus sequence. This region
overlaps the predicted -35 site of hemS but does not extend to the -10 site. Identification
of motifs similar to the H-box and surrounding consensus sequence in the promoter
region of hutA/tonB and hemS is consistent with qRT-PCR data showing repressive
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effects of irr overexpression on hut locus expression (Fig. 3-4C, p. 72). Together, these
results suggest Irr represses transcription of hut locus genes by binding at or near RNA
polymerase recognition sites.

E. DISCUSSION

Genomic analyses of the B. quintana genome show multiple systems possibly
involved in hemin and/or iron acquisition. One of these, the hut locus, appeared to be the
most likely and complete candidate for a hemin uptake system. Based on multiple lines
of in silico evidence, including amino acid similarity, domain conservation, and structural
similarity, we hypothesized that HutA was functioning as a hemin receptor (Fig. 3-1, p.
66).
We tested the hypothesis by functional expression of B. quintana hutA in E. coli hemA
strain EB53 (12, 41). Expression of hutA trans-complemented EB53 was tested in the
presence of hemin at two concentrations (Fig. 3-2, p. 68). The E. coli hemA strains have
a leaky phenotype which accounts for the low level increase in optical density over time
(41). The results required an ~12-16 h lag before a difference in growth rates was
discernible between complemented and control strains. This observation may be due to
limited homology between TonB and TonB boxes of B. quintana and E. coli (30).
Nevertheless, sufficient homology in TonB allowed B. quintana HutA to function as a
hemin receptor in EB53, whereas HutA could not complement an otherwise isogenic E.
coli strain (IR754) where both tonB and hemA are mutagenized (Fig. 3-2, p. 68).
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The B. quintana hut locus is similar to other bacterial hemin acquisition systems in
that it is transcriptionally regulated in a hemin-responsive manner (Fig. 3-3, p. 69).
Growth on low hemin results in a slight increase in hut locus mRNAs relative to the
quantity obtained from growth on optimal hemin. Although the difference in hemin
concentrations between BA-2.5mM hemin and BA-0.15mM is much greater, the decrease
in hut gene transcription is fairly modest. Based on these data, it is tempting to speculate
that changes in extracellular hemin are buffered in B. quintana, possibly by an accessory
hemin-binding system, such as the Hbps. Such a system could enhance the ability of B.
quintana to withstand hemin fluctuations in the divergent environments of the body louse
and human bloodstream.
Effects of overexpression of hemin/iron-responsive regulators (irr, rirA, and fur)
indicate that hemin-responsive changes in hut locus transcription are primarily mediated
by Irr. Although Irr homologs have been reported to act as transcriptional activators of
hemin/iron genes when hemin is limiting (25, 39), B. quintana Irr represses hut locus
genes. B. quintana Irr may also transcriptionally activate hut locus genes in the absence
of hemin, but the absolute requirement for hemin by B. quintana prohibits investigating
this possibility (31). Our data suggest that irr overexpression results in repression of hut
locus genes regardless of ambient hemin concentration, despite previous reports
suggesting that B. japonicum Irr is degraded upon binding hemin (51). Interestingly, the
N-terminal heme response motif (amino acids 28-33) of B. japonicum Irr is not conserved
in B. quintana Irr (51). Likewise, only two of three histidine residues implicated in a
second hemin-binding site (51) are present in B. quintana Irr and both B. quintana and E.
coli Fur have two histidines in this position but are not degraded by hemin (data not
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shown). B. japonicum Irr represses protoporphyrin biosynthesis genes when heme is
present, but the majority of these genes are not present in the B. quintana genome
suggesting that B. quintana Irr plays a distinct role (6, 36). Of specific interest, hememediated degradation of Irr in B. japonicum requires ferrochelatase (36), but an
orthologue is absent in B. quintana (2).
RT-PCR analyses show that the hut locus is expressed as three transcripts, originating
from a divergent promoter region between hutA and tonB and a polycistronic mRNA
transcribed from the region upstream of hemS (Fig. 3-5, p. 73). Consistent with qRTPCR data from the irr overexpression strain, both promoters possess regions with
considerable identity to a consensus sequence containing H-box (Fig 3-6, p. 74-5) (6).
Unlike Hbps, the majority of which were activated by Irr, the consensus sequence
encompassing H-box in the hut locus promoters either overlaps the -10 and -35 regions
(hutA) or is located nearby (tonB and hemS). A similar location for the ICE motif was
reported in B. japonicum genes repressed by Irr (39, 40). These data strongly suggest that
Irr directly represses the hut locus.
In contrast to irr, rirA overexpression showed only minor changes in transcription of
hut locus genes, regardless of hemin concentration (Fig. 3-4C, p. 72). In the presence of
excess hemin, fur overexpression resulted in decreased transcription of tonB (Fig. 3-4B,
p. 71). However, no obvious consensus Fur box sequence is evident in the promoter
region of tonB (15). The effect of fur overexpression on tonB may be indirect in B.
quintana, but this seems unlikely as tonB is known to be repressed by Fur in other
bacteria (32). Most likely, Bartonella Fur recognizes a unique consensus sequence, as
described for B. japonicum (15).
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To our knowledge, this is the first study to characterize a complete system of hemin
acquisition in Bartonella. Our data indicate that the hut locus is surprisingly similar to
hemin uptake systems described in other Gram-negative bacterial pathogens and is
primarily controlled by Irr. However, given the importance of hemin to the survival and
pathogenesis of Bartonella, B. quintana provides a unique model for studying its
acquisition and utilization. Interesting areas of future study include the interplay between
the Hut proteins and potential accessory systems including proteins able to bind hemin
(e.g., Hbp’s), proteins able to remove heme from hemoglobin, and proteins able to
function as hemoglobin receptors. Any of these systems would contribute to the success
of Bartonella pathogenesis by buffering fluctuations in available heme and by allowing
Bartonella to use the most abundant source of heme in the human host (16).

F. ACKNOWLEDGEMENTS

We thank Jane Koehler (UC San Francisco) for B. quintana strain JK31 and Christopher
Elkins (UNC Chapel Hill) for E. coli strains EB53 and IR754 and helpful discussions
regarding complementation. We thank Patty McIntire (Murdock Sequence Facility) for
providing sequence analyses and Rahul Raghavan for helpful discussions.

We are

grateful to Kate Sappington, Laura Smitherman, Linda Hicks, Jessica Clark, and Sean
Wolf for technical assistance. This work was supported by Public Health Service grant
R01 AI053111 from the National Institutes of Health to M.F.M..

67

Table 3.1. Bacterial strains and plasmids used in this study.

Strains and plamids

Description

Source or
reference

Low-passage human isolate
JK31 with pBBR1MCS
JK31 with pBBR-FUR
JK31 with pBBR-RIRA
JK31 with pBBR-IRR

J. Koehler
(6)
(6)
(6)
(6)

Host strain for cloning
Host strain for cloning
hemA aroB rpoB
EB53 but tonB::Kan
EB53 harboring pWSK29
EB53 harboring pNP1
IR754 harboring pWSK29
IR754 harboring pNP1

Promega
Invitrogen
(47)
(47)
This study
This study
This study
This study

Strains
B. quintana
JK31
JK31+pBBR
JK31+pBBR-FUR
JK31+pBBR-RIRA
JK31+pBBR-IRR

E. coli
JM109
TOP10F’
EB53
IR754
EB53/pWSK29
EB53/pNP1
IR754/pWSK29
IR754/pNP1
Plasmids
pCR2.1TOPO
pNP2
pWSK29
pNP1
pQE30
pNP3
pBBR1MCS
pBBR-FUR
pBBR-RIRA
pBBR-IRR

TA cloning vector
pCR2.1TOPO containing B. quintana hutA
Low copy-number expression vector
pWSK29 containing B. quintana hutA
Expression vector for 6xHis-tagged fusion proteins
pQE30 containing B. quintana hutA
Shuttle vector for Bartonella
pBBR1MCS containing B. quintana fur
pBBR1MCS containing B. quintana rirA
pBBR1MCS containing B. quintana irr
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Invitrogen
This study
(50)
This study
Qiagen
This study
(21)
(6)
(6)
(6)

Figure 3-1. Arrangement and homology of B. quintana hemin uptake locus.
A. Genomic arrangement of the B. quintana hut locus and BLAST results indicating
closest orthologues outside Bartonellaceae (percent amino acid identity: percent amino
acid similarity), as well as predicted: function, isoelectric point (pI) and mass (kDa).
B. ClustalW alignment of C-terminal region of B. quintana HutA with
hemin/hemoglobin receptors of Yersinia enterocolitica (HemR), Y. pestis (HmuR), and
Haemophilus influenzae (HxuC). Conserved FRAP and NPNL domains are boxed and
shaded. The tyrosine 505 substitution aligned with typically conserved histidines is
indicated by bold-face type. Fully conserved residues are indicated by a star, a colon
shows strongly conserved residues, and a dot indicates weakly conserved residues.
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Figure 3-2. Complementation of E. coli hemA strains with B. quintana hutA.
Growth curve of E. coli EB53 and IR754 containing pWSK29 (vector control) or pNP1
inoculated into TY supplemented with: A) 10µg/ml or B) 50µg/ml hemin after a brief
period of hemin/ALA starvation. The asterisk (*) indicates a statistically significant
difference in OD600 relative to controls.
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Figure 3-3. qRT-PCR analysis of B. quintana hut locus transcription in response to
hemin availability. Average fold differences in hut locus transcript levels from JK31
grown under hemin-limiting conditions (0.05mM) or excess hemin (2.5mM) relative to
optimal levels (0.15mM). Data represent the means of three independent determinations
(per gene per condition) +/- standard deviation.
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Figure 3-4. qRT-PCR analyses of B. quintana hut locus in response to
overexpression of various iron response regulators. Average fold difference in hut
locus transcription from: A) JK31+pBBR-RIRA, B) JK31+pBBR-FUR and C)
JK31+pBBR-IRR relative to JK31+pBBR. Strains were grown in parallel on BA0.05mM hemin, BA-0.15mM hemin, and BA-2.5mM hemin. Data represent the means
+/- standard deviation of three independent determinations.
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Figure 3-5. RT-PCR analysis verifies polycistronic nature of hut mRNA.
PCR analysis of hmuV transcript components using gene-specific primers for each
member of the hut locus except tonB. (G), genomic DNA from JK31 used as template;
(+), hmuV RT product used as template; (-), JK31 RNA without reverse transcription
used as template. DNA size standards are indicated in kbp on left and bp on right side of
gel.

76

Figure 3-6. TSS mapping and promoter regulatory regions of the hut locus showing
the H-box.
A. TSS’s mapped by 5’RACE are indicated by a diamond (hutA) and arrowhead (tonB).
Putative -10 and -35 promoter elements are shown with directionality, and the horizontal
arrow and bold-face type indicate the hutA and tonB genes. The consensus sequence that
interacts with B. quintana Irr (6) is boxed.

Note the consensus is on the inverse

complement (lower) strand.
B. TSS of hems is indicated in bold by the star. Potential -10 and -35 sites are indicated
and the region containing the consensus sequence that interacts with B. quintana Irr (6) is
boxed. The hemS gene is indicated by the horizontal arrow and bold-face type.
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CHAPTER FOUR
Bartonella quintana HemS is a Hemin Binding Protein with Potential Heme
Oxygenase Activity

A. INTRODUCTION

An extraordinarily high hemin requirement for in vitro growth is a hallmark of
Bartonella species, and meeting this requirement is undoubtedly pivotal to its ability to
cause disease in the context of the human host. Recent work with Bartonella quintana
has focused on the mechanisms of hemin acquisition resulting in the characterization of
the hemin utilization locus (hut) and the hemin binding protein family members (HbpAE). The ability to obtain iron, either free or from the breakdown of heme, is largely
undefined in Bartonella. It has been established that iron and protoporphyrin IX are not
sufficient for in vitro growth in the absence of hemin itself, but this may result from the
lack of ferrochelatase rather than the inability to acquire iron (4, 152). Analysis of the B.
quintana genome indicates two potential systems for iron uptake, namely the yfe (A-D)
locus for manganese, zinc, and possibly ferric iron acquisition and the ceuD/fat (B-D)
locus for siderophore-mediated iron acquisition (4). However, the B. quintana yfe locus
lacks a homolog to yfeE, which was shown to be an essential component of the Yersinia
system in complementation assays of an E. coli enterobactin mutant (15). Furthermore,
there are no obvious candidates for siderophore synthesis genes in the B. quintana
genome (Battisti and Minnick, unpublished observations). In addition to the ambiguity
surrounding iron uptake, the mechanism of protection from heme-mediated cytotoxicity
is unclear. One potential solution that provides iron and neutralizes heme-mediated
oxidative damage is the utilization of a heme oxygenase (HO).
Originally characterized in mammalian cells, membrane associated HOs act in
conjunction with NADPH-cytochrome P450 reductase to catalyze the breakdown of
heme into biliverdin, carbon monoxide (CO) and free iron (Fe2+). Biliverdin is then
converted by biliverdin reductase to bilirubin (94). Heme breakdown can also occur via
coupled oxidation which, like HO-mediated catabolism, generates meso-hydroxyheme
and verdoheme intermediates. However, the two reactions can be distinguished by
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inhibitors and end products. In particular, coupled oxidation does not occur in the
presence of catalase whereas HO-mediated catabolism does. Also, coupled oxidation
nonspecifically degrades heme generating a mix of biliverdin isomers, whereas HOmediated catabolism proceeds to the specific generation of α-biliverdin in almost all
instances (10, 94). Although the detoxification of free heme is thought to be the primary
function of mammalian HOs, secondary functions include protection from cellular injury
through generation of the antioxidants biliverdin and bilirubin and maintenance of
homeostasis through CO signaling (19, 94) .
Unlike the situation described in eukaryotes, bacterial HOs are soluble, their in vivo
reductase partners are largely undefined, the fate of biliverdin is unclear, and their
primary function is presumably to release iron from heme. Due in part to considerable
homology with human HO-1, one class of bacterial HO has been characterized in the
Gram-positive pathogen Corynebacterium diphtheriae (192). Another example is the
Gram-negative Neisserial HemO protein which also bears some resemblance to
eukaryotic HOs. Studies suggest that the Neisserial HemO degrades heme into ferricbiliverdin IXα and CO rather than releasing free iron and biliverdin, but this may be the
result of a weak interaction with a surrogate reductase partner (198). In Pseudomonas
aeruginosa, PigA also has homology to the HemO/HmuO class of heme oxygenases and
has been shown to function as such (140). Of note, this HO, like coupled oxidation,
generates a mixture of biliverdin IX-β and biliverdin IX-δ rather than the biliverdin IX-α
product characteristic of HO-catalyzed heme degradation. It is also unable to efficiently
interact with the NADPH-cytochrome P450 reductase (140). The widespread use of
heme by pathogenic bacteria implies that utilization of a HO to liberate iron from heme
might also be widespread. Interestingly, one report indicates that database searches of
bacterial genomes have identified homologs to HmuO and HemO in only Deinococcus
and Legionella, suggesting that either the strategy of iron release from heme via HOmediated degradation is rare or that many bacterial species encode a novel HO enzyme
(140).
Not surprisingly, analysis of the B. quintana genome also indicates the absence of a
mammalian HO homolog, but it does encode a potential hemin-degrading protein, HemS.
The precise function of HemS homologs is somewhat controversial. Initial experiments
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suggested that the Shigella dysenteriae homolog, ShuS, formed an oligomeric ferritin-like
structure that functions as a heme-storage protein (191). This result was modified to
suggest that ShuS complexed with heme exists as a dimer, while the oligomeric structure
arises from heme-free ShuS bound to DNA (91). This occurrence led Kaur and Wilks to
hypothesize a Dps-like role in protection of DNA from oxidative stress, but ShuS-bound
DNA was not fully protected from oxidative stress and shuS was not able to complement
an E. coli dps mutant (91). Examination of the P. aeruginosa homolog, PhuS, indicates
that heme can be degraded by this protein in the absence of catalase but not in its
presence. The authors attributed degradation to the coupled oxidation mechanism and
proposed that PhuS functions as a heme-trafficking protein that facilitates the transfer of
heme to PigA (106). The closely related Yersinia enterocolitica HemS was required for
efficient utilization of heme as an iron source, but not as a porphyrin source, in
complementation studies involving E. coli EB53 (165). Y. enterocolitica HemS was also
required to prevent cytotoxicity, presumably resulting from the accumulation of excess
heme, in E. coli strains expressing the recombinant hemin receptor, HemR, from a highcopy plasmid (166). Based on these observations, heme oxygenase activity was proposed
for HemS despite the absence of sequence similarity to known HOs or experimental
evidence of this catabolic capability (166, 192). Evidence of enzymatic activity was
obtained for the ChuS homolog from E. coli O157:H7, which was shown to function as a
HO by specific degradation of heme accompanied by generation of carbon monoxide in
the presence of an electron source, in vitro. The generation of free iron and biliverdin
was assumed based on spectral data and culture pigmentation (169). The suggestion that
ChuS-mediated heme degradation occurs via coupled oxidation was addressed by the
addition of catalase or superoxide dismutase to the reaction. Neither of these agents
inhibited the decomposition of heme, but mutagenesis of a highly conserved histidine
residue completely abolished enzymatic activity (168). These data provide strong
evidence for the existence of a novel HO that has homologs in many bacterial species.
Due to the fact that heme is assumed to be the primary source of iron and porphyrin in
the human host, especially in the intracellular erythrocyte environment, we hypothesized
that HemS functions as a heme oxygenase. However, it should be noted that hemetrafficking/chaperone functions are not necessarily exclusive of heme oxygenase
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functions. These studies were undertaken to elucidate the function of HemS in an effort
to better understand heme/iron acquisition in Bartonella.

B. MATERIALS AND METHODS

Bacterial strains, media, and culture conditions. E. coli strains were routinely
grown overnight at 37oC in Luria-Bertani (LB). Gene expression was induced by the
addition of 0.1 mM to 2.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG) to mid-log
phase cultures prior to an additional 4-6 h incubation. Corynebacterium ulcerans strains
CU712 hmuO∆ and CU712 hmuO∆/pCUhmuO (generously provided by Michael
Schmitt) were routinely grown overnight at 37oC in heart infusion broth (HIB) containing
0.2% Tween 80 (HIBTW) unless otherwise stated (104, 135). Standard antibiotic
concentrations were supplied as needed. Strains used in this study are listed in Table 4.1
(p. 94).

Analysis of sequence and structural similarity. The National Center for
Biotechnology Information website (http://www.ncbi.nlm.nih.gov) and the RhizoDB
website (http://xbase.bham.ac.uk/rhizodb/) were used for genome searches and sequence
retrievals. Multiple amino acid sequence alignments were performed with ClustalW
version 2.0 and comparison with sequence databases were performed with BLAST (5,
108). Structural predictions were made with the Protein Homology/Analogy Recognition
Engine (Phyre) version 0.2 (http://www.sbg.bio.ic.ac.uk/~phyre/) (92).

DNA preparations and plasmid construction. A DNeasy blood and tissue kit
(Qiagen, Valencia, CA) was used for the preparation of genomic DNA. Small-scale
plasmid purification was performed with a QIAprep miniprep kit (Qiagen) and largescale preparations were obtained with a Wizard Plus midiprep kit (Promega, Madison,
WI). Standard protocols were employed for PCR amplification, restriction digestion,
ligation, and cloning (8). Primers used in this study are listed in Table 4.2 (p. 95).
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HemS expression and purification. Overnight cultures of JM109/pQE30HemS were
expanded and grown to mid-log phase then induced with 2.5 mM IPTG for 5-7 h. Cells
were centrifuged at 10,000 x g for 10 min at 4oC, and resulting pellets were placed in 20oC until needed. Because attempts to purify soluble His6-tagged HemS resulted in very
low yields, purification was performed under denaturing conditions per QIAexpressionist
(Qiagen) protocol with minor modifications. Briefly, denatured HemS was purified with
Ni++NTA (nickel nitrilotriacetate) resin per protocol except the column was washed twice
with 4 mls Buffer C each time. Elution was monitored by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) using 12.5% (wt/vol) acrylamide gels,
which indicated partial purification of HemS in the third and fourth fractions of Buffer E.
These fractions were combined and refolded against dialysis buffer (100 mM NaH2PO4,
600 mM NaCl, 20% glycerol, pH 8.0) in a 3500 MWCO (molecular weight cut-off)
Slide-a-Lyzer cassette (Pierce, Rockford, IL) (135). Re-folded HemS was concentrated
with PEG [poly(ethylene glycol)] 20,000 (Alfa Aesar, Ward Hill, MA). Pooled samples
were further concentrated by ultrafiltration using an amicon stir cell with a 30,000
MWCO membrane. Samples were stored at -20oC until needed.

Spectral analysis of hemin binding. Hemin binding to HemS was assessed
spectrophotometrically with an HP8453 A diode array UV/VIS spectrophotometer.
Briefly, 81.25 nM of hemin was added incrementally to the sample cuvette containing 3
ml of HemS (27µM/L) or the reference cuvette (containing buffer only) in 6.25 nM
aliquots. Hemin was incubated with HemS for 5 min at room temperature after each
addition, and the absorbance spectrum from 300 nanometers (nm) to 800 nm was
recorded for each. Data obtained for the reference cuvette were subtracted from data
obtained from the sample cuvette to generate difference spectra. Data from two
independent experiments were used for nonlinear regression analysis with Prism software
from GraphPad (http://graphpad.com).

Hemin blots. A bicinchoninic acid protein kit (Sigma Chemicals, St. Louis, MO) was
used for protein quantification. SDS-PAGE followed the general methods of Laemmli
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(105). Gels were stained with Coomassie brilliant blue for visualization or transferred to
nitrocellulose according to the methods of Towbin (8, 173). Hemin blots were basically
performed as described (31). In brief, blots were blocked for 1 h with Tris-buffered
saline (TBS-Tween 20) (10 mM Tris, 150 mM NaCl, 0.1% Tween 20) containing 2%
nonfat dry milk then washed twice with TBS. Blots were then incubated for 1.5 h in
TBS-Tween 20 containing 10 µg/ml hemin, washed three times (30 min each) in TBSTween 20, developed using enhanced chemiluminescence (ECL) reagents (Pierce,
Rockford IL) and visualized with autoradiographic film (Eastman Kodak Co., Rochester,
NY).

Electroporation of Corynebacterium. Corynebacterium ulcerans strains were
transformed essentially as described (74). Ten ml of overnight CU712hmuO∆ culture
was used to inoculate 100 ml of HIBTW supplemented with 20 ml of 20% glycerol.
Cultures were incubated 1 h at 37oC then diluted to OD600 ~0.4. Cells were centrifuged at
10,000 x g for 10 min at 4oC and the resulting pellet was washed with 200 ml cold 15%
glycerol. Cells were centrifuged again and resuspended in a final volume of 400 µl cold
15% glycerol. A 40 µl volume of this suspension was mixed with plasmid DNA (1.4 µg
to 34.3 µg) in a 2mm gap electroporation cuvette (BTX, Holliston, MA). Cells were
electroporated with a GenePulser (Bio-Rad, Hercules, CA) set at 2.5kV, 25µF and 200Ω.
HIBTW (900 µl per cuvette) was added immediately after the pulse and cells were
incubated at 30oC for 1.5 h prior to plating.

Complementation of C. ulcerans hmuO∆
∆. Complementation of C. ulcerans was
performed as described previously (135). In brief, the C. ulcerans CU712hmuO∆ strain
was transformed with the E. coli-Corynebacterium shuttle vector pKN2.6Z (kindly
provided by M. Schmitt) containing B. quintana hemS (46). CU712hmuO∆ containing
vector only served as a negative control and CU712hmuO∆/pCUhmuO served as a
positive control. Strains were grown overnight at 37oC in HIBTW then diluted 1:1000.
25 µl aliquots of these dilutions were used to inoculate HIBTW supplemented with 200
µg/ml of the iron chelator ethylenediamine-N,N’-bis(2-hydroxyphenyl acetic acid)
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(EDDHA), alone, or in conjunction with 1 mM FeSO4 or 7 µM hemin. Plates were
scored for visible growth following overnight incubation at 37oC.

DNA Sequencing. An automated DNA sequencer (AB3130x1 genetic analyzer) and
a BigDye Terminator cycle sequencing ready reaction kit 3.1 (ABI, Foster City, CA)
were used to obtain sequence data. Data were analyzed with ChromasPro 1.13 software
(http://www.technelysium.com.au/ChromasPro.html).

C. RESULTS

Sequence conservation and predicted structural similarities between B.
quintana HemS and E. coli ChuS. Initial examination of B. quintana HemS focused on
identifying similarities to other HemS homologs, specifically concentrating on the E. coli
ChuS protein. BLAST analyses of ChuS from 0157:H7 against the B. quintana genome
indicate 33% amino acid identity and 50% similarity across 327 of 347 HemS residues.
The crystal structure of ChuS has been solved and indicates a novel HO structure
consisting of 9 anti-parallel β-strands contributing to the formation of two large β sheets
(168, 169). Several amino acids required for stabilization of the heme-binding interaction
or enzymatic activity were identified. Clustal alignment of HemS with ChuS indicates
complete conservation of all amino acid residues involved in stabilization of heme
binding except for the replacement of one tyrosine (Tyr 315) with a phenylalanine in B.
quintana HemS (See Fig. 4-1A, p. 96). Most importantly, the key histidine residue (His
193) for coordinating heme and required for oxygenase activity is conserved, as is the
second coordinating residue, Arg 100 (168). The predicted three-dimensional structure
of B. quintana HemS aligned with the E. coli ChuS structure determined by
crystallography. This alignment shows positional conservation of the heme coordinating
residues within the heme-binding cleft identified by crystallization of the ChuS-heme
complex (Figure 4-1B, p. 97). Although HemS and ChuS share relatively low amino acid
identity, these data suggest that the majority of critical residues for heme binding and
oxygenation are conserved and the two proteins share a high degree of structural
homology.
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His6-tagged HemS expression and hemin binding in E. coli. The successful
construction of a pQE30 plasmid encoding a his6-HemS fusion, termed pQE30HemS,
was initially confirmed by DNA sequencing. Sequence analyses indicate the presence of
a point mutation resulting in the substitution of an arginine residue at position 10 (Arg
10) with a leucine (data not shown). Despite the presence of this mutation, all
experiments were performed using this clone. This decision was justified in part by
difficulties in obtaining the clone and in part by the fact that Arg10 is not conserved in
ChuS (See Fig. 4-1A, p. 96). Protein synthesis was confirmed by SDS-PAGE and those
analyses indicate production of a unique inducible protein of ~40 KDa (See Fig. 4-2A, p.
98). This is in accordance with the predicted molecular mass of 39.4 KDa for native
HemS. Expression of recombinant HOs in E. coli can confer a blue-green pigment to
cells that others have attributed to the accumulation of biliverdin (169, 198). However,
this phenomenon was not observed during expression of the B. quintana His6-HemS
protein regardless of expression level. Examination of the hemin binding ability of
HemS by hemin blotting indicates that His6-HemS binds hemin at levels well above
background (See Fig. 4-2B, p. 98). Based on these data, the His6-HemS protein is
expressed and inducible in E. coli. Although HemS synthesis does not generate visible
indications of biliverdin accumulation, it is able to bind hemin in a strong and specific
manner independently of Arg 10.

Spectral analyses of hemin binding. For further exploration of the hemin binding
capacity of His6-HemS, the protein was purified and renatured for spectrophotometric
analysis of heme binding. Difference spectra were obtained by subtracting the
absorbance of hemin in buffer alone from the spectra obtained from hemin added to His6HemS in buffer. These difference spectra, similar to those obtained from other HOs,
show a Soret maximum at 411 nm which is indicative of hemin binding (See Fig. 4-3A,
p. 99). Additionally, the absorbance of bound hemin in 350 nm range is lower than that
obtained from free hemin resulting in a trough (B. Lei, personal communication).
Although β and α bands (at ~545 and 580nm, respectively) have been reported for other
bacterial HOs, they are not evident in the difference spectra obtained for the hemin-His6-
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HemS complex. Presumably, the absence of these bands is due to the relatively low
concentration of His6-HemS compared to the concentrations of protein used in other
studies (140, 169). Nonlinear regression analyses of the change in absorbance at 411 nm
(∆OD411) versus hemin concentration best fit a one-binding site model (See Fig. 4-3B, p.
100). The estimated Kd is 5.9 + 1.7 µM and the increase in absorbance appears to even
out at ~25 µM suggesting a 1:1 ratio of hemin to protein. The estimated Kd reported here
is higher (lower affinity) than that reported for several HOs, but fairly close to the
estimated Kd of the IsdG hemin-degrading enzymes of Staphylococcus aureus and
Bacillus anthracis (159, 160).

B. quintana HemS does not complement a C. ulcerans CU712hmuO∆
∆ strain.
Attempts to reconstitute HemS heme oxygenase activity in vitro have been unsuccessful
to date. An alternative strategy for examining the function of HemS is the
complementation of a HO mutant strain. Unfortunately, few such strains exist. Despite
the distant relationship between B. quintana and C. ulcerans and the fact that HmuO
represents a different class of bacterial HO, the existence of CU712hmuO∆ provided a
potential strain for complementation assays in an attempt to define the function of HemS
in vivo (104). In order to explore the hypothesis that hemS could functionally repair the
hmuO defect, the B. quintana hemS gene was cloned into the Corynebacterium-E. coli
shuttle vector pKN2.6Z. Of note, attempts to identify or induce HemS from pKN2.6Z in
E. coli were unsuccessful but the presence of the insert was confirmed by PCR and DNA
sequencing (data not shown). CU712hmuO∆ strains containing pKNHemS or pKN2.6Z
alone were tested for the ability to utilize hemin as the only source of iron. Control
strains included the mutant, CU712hmuO∆, and the mutant strain complemented with its
own hmuO gene, CU712hmuO∆/pCUhmuO. As expected, none of the strains grew on
iron-chelated media and all of the strains grew on media supplemented with FeSO4. Like
CU712hmuO∆, CU721hmuO∆/pKNHemS was unable to grow on plates supplemented
with hemin. In contrast, the strain complemented with C. ulcerans hmuO grew well with
hemin as a sole iron source (See Fig. 4-4, p. 101). These results show that B. quintana
hemS is not sufficient to restore growth of the C. ulcerans hmuO∆ strain on iron-depleted
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medium supplemented with hemin. Not surprisingly, in light of the inability to induce
HemS expression in E. coli, supplementation of media with IPTG did not alter these
results.

D. DISCUSSION

Although one hemin acquisition system, the Hut locus, has been characterized in B.
quintana, neither the fate of hemin in the cytoplasm nor the mechanisms used for iron
acquisition are currently understood. We hypothesized that one member of the Hut locus,
HemS, was able to bind and degrade hemin. The data presented herein clearly indicate
that HemS has amino acid and structural similarities to the E. coli HO, ChuS, and that
HemS is able to bind hemin. Experiments performed to date have not provided in vitro
or in vivo evidence of heme oxygenase activity. Nevertheless, these results may be
ascribed to the generation of a spurious mutation while cloning hemS and the
complementation system chosen rather than an authentic absence of enzymatic activity.
With respect to the mutation of Arg10 in HemS, the replacement of the positively
charged, basic side chain of arginine with the nonpolar side chain of leucine may have
altered proper folding of HemS. The inability to purify large quantities of soluble His6HemS may also be attributable to this mutation, as several studies report the generation of
soluble recombinant His-tagged heme oxygenases (140, 169, 198). Alternatively, the
inability to reconstitute in vitro HO activity may simply have resulted from relatively low
concentrations of His6-HemS compounded by potentially incomplete renaturation. The
use of a C-terminal histidine tag or a glutathione-S-transferase (GST) tag will be
considered for future cloning and purification attempts. Until these potential issues have
been resolved, the ability of HemS to function as a heme oxygenase in vitro cannot be
ascertained with any confidence.
With respect to the C. ulcerans complementation system, it was initially chosen due to
the absence of an alternative HO mutant strain. However, the fact that HmuO represents
a different class of HO presents at least one potential pitfall that could result in the
inability of one class to substitute for the other. Namely, the two classes of bacterial HOs
may utilize different reductase partners in vivo. In support of this explanation, the P.
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aeruginosa HO, PigA, which also belongs to the HmuO/HemO class of bacterial HOs
was unable to efficiently use the NADPH-cytochrome P450 reductase system for in vitro
heme degradation (140). As with the in vitro experiments, there are too many potential
problems with the complementation assays for these negative data to definitively rule out
the hypothesis that HemS possesses heme oxygenase activity.
An E. coli chuS mutant in an 0157:H7 background was recently generated, and may
provide an alternative complementation system (176). The phenotype of this strain is
currently unknown, but it may be unable to use hemin as a sole iron source if grown on
iron-depleted media. In an effort to overcome the difficulties associated with attempting
to complement the CU712hmuO∆ strain, collaborations are currently planned to examine
the phenotype of the chuS mutant and, if an appropriate phenotype exists, attempt to
complement it with B. quintana hemS (C. Martin, personal communication). Provided
the mutant has a testable phenotype, the utilization of an E. coli chuS strain for
complementation assays has a much higher chance of succeeding because of the
homology between ChuS and HemS.
A final point of interest, albeit speculative, regarding potential heme oxygenase
activity in B. quintana is the existence of a hypothetical gene (BQ09510) that shares 22%
identity and 44% similarity with 165 of 296 amino acids of human biliverdin reductase
A. Moreover, BQ09510 also shares 23% identity and 41% similarity across 254 amino
acids to the cyanobacterial biliverdin reductase, BvdR (155). In addition to implying HO
activity in B. quintana, a biliverdin reductase would also supply a cycling mechanism for
the powerful antioxidant bilirubin. Evidence from mammalian cells suggests that minute
amounts of bilirubin can protect lipids from massive hydrogen peroxide challenge. The
ability of low concentrations of bilirubin to be highly cytoprotective has been attributed
to the fact that oxidization of bilirubin generates biliverdin which is in turn reduced back
to bilirubin by biliverdin reductase (157). Thus, examination of the function of BQ09510
would be an interesting avenue for future studies in terms of elucidating both heme
metabolism and the closely related oxidative stress response.
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Table 4.1. Bacterial strains and plasmids used in this study.

Strain or plasmid

Description

Source or reference

Strain
B. quintana
JK31

low passage human isolate

J. Koehler

E. coli
JM109
TOP10F'

Host strain for cloning
Host strain for cloning

Promega
Invitrogen

C. ulcerans
CU712humO ∆
CU712hmuO ∆/pCUhmuO
CU712hmu O∆/pKN2.6Z
CU712hmuO ∆/pKNHemS

CU712 with a 305bp internal deletion of hmuO
CU712hmuO ∆ harboring pCUhmoO
CU712hmuO ∆ harboring pKN2.6Z
CU712hmuO ∆ harboring pKNHemS

M. Schmitt
M. Schmitt
This study
This study

Corynebacterium-E. coli shuttle vector
pKN2.6Z with B. quintana hemS
Expression vector
pQE30 with B. quintana hemS

M. Schmitt
This study
Qiagen
This study

Plasmid
pKN2.6Z
pKNHemS
pQE30
pQE30HemS
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Table 4.2 Primers used in this study.

Primers
SacIhemSfor
HindIIIhemSrev
SalIhemSfor
EcoRVhemSrev

TGAGCTCGCTGAAACGATTATTCGTTTGC
GGGAAGCTTTCGATATTTTTCAGCTTTGG
CATGTCGACCTATGGCACATAAAGCTGAAACG
GGATATCCGATATTTTTCAGCTTTGGGGC

98

A)

Figure 4-1. Similarity of B. quintana HemS to the E. coli heme oxygenase ChuS. A)
Clustal alignment of B. quintana HemS with ChuS from E. coli 0157:H7 strain EDL933.
Conserved residues involved in heme binding are boxed and shaded and the histidine
(His193 of E. coli) required for enzymatic activity is indicated by the large star. A dot
indicates weakly conserved residues, a colon indicates strongly conserved residues, and a
star indicates fully conserved residues. B) Three-dimensional model of HemS shows
structural similarity to E. coli ChuS. The predicted positions of conserved residues
required for coordinating and degrading heme are highlighted in yellow.
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B)

100

A)

B)

Figure 4-2. Recombinant his6-tagged HemS is able to bind hemin. Lanes: 1,
JM109/pQE30 (uninduced); 2, JM109/pQE30 (induced); 3, JM109/pQE30HemS
(uninduced); 4, JM109/pQE30HemS (induced). A) Coomassie blue stained SDS-PAGE
gel. B) Corresponding hemin blot showing hemin bound to HemS. Molecular mass
standards are indicated on the left in kilodaltons.
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A)

Figure 4-3. Spectral analysis of hemin binding. A) Difference spectra of His6-HemS
with increasing amounts of hemin added shows a Soret maximum at 411 nm and a trough
peak at ~350 nm. The increased absorption at 411 nm following addition of increasing
amounts of hemin is indicated by the arrow. B) Nonlinear regression of the change in
absorbance at 411 nm versus the concentration of hemin. Data shown are the mean and
standard deviation of two independent experiments.

102

B)
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Strain
CU712hmuO ∆

Supplement
1mM FeSO4
+++

200µg/ml EDDHA
No growth

7µM Hemin
No growth

CU712hmuO ∆/pCUhmuO

No growth

+++

+++

CU712hmuO ∆/pKN2.6Z

No growth

+++

No growth

CU712hmuO ∆/pKNHemS

No growth

+++

No growth

Figure 4-4. Complementation of C. ulcerans hmuO∆
∆ strains. Strains were plated to
HIB containing 200 µg/ml EDDHA alone, or supplemented with 1 mM FeSO4, or 7 µM
hemin and visually scored for growth after overnight incubation. “+++” indicates a lawn.
Results are representative of three separate experiments.
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CHAPTER FIVE

DISCUSSION

Neither free iron nor free hemin is abundant in the human host and the scarcity of
these nutrients is exacerbated by the innate iron/hemin sequestration response to infection
(186). Pathogens must overcome these limitations if they are to be successful.
Elucidation of the mechanisms and control of bacterial hemin/iron acquisition will
enhance understanding of this aspect of bacterial adaptation to its host environment, may
indicate novel regulation of virulence determinants in response to environmental cues,
and has the potential to identify novel targets for the generation of new antimicrobial
agents by rational drug design. The need for novel antibiotics is predicted to become
increasingly urgent due to the continued emergence of multidrug resistance in several
pathogens (128) Previous studies indicated that Bartonella required an extraordinary
amount of hemin for in vitro growth, possessed a novel family of hemin binding proteins
(HbpA-E), and was able to rapidly shift between the extreme differences in free hemin
availability found in the human host and the body louse (123, 152). These reports laid
the foundation for the current studies, which were undertaken with the aim of
characterizing the hemin/iron acquisition and regulation mechanisms employed by B.
quintana.
The initial exploration of potential hemin receptors focused on the Hbps. An HbpA
homolog, Pap31, from B. henselae reportedly functioned as a hemin receptor when
recombinantly expressed in E. coli and the hbp genes were shown to be transcriptionally
responsive to the alteration of external cues associated with colonization of either the
body louse or the human blood stream, including oxygen and hemin concentration (13,
199). Contrary to the prevailing hypothesis of the time, B. quintana HbpA was unable to
function as a hemin receptor in E. coli. The exact function of the Hbps is still unclear,
but their importance in mediating human infection is underscored by the fact that one of
them (HbpE) is a predominant outer membrane protein recognized by sera obtained from
infected individuals (23). Furthermore, their specific interaction with both hemin and
hemoglobin suggests this binding has a biologically relevant purpose. The potential
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relevance of the hemin/hemoglobin interaction is accentuated by the fact that the closely
related Neisserial opa genes are upregulated when cells are grown on media containing
hemoglobin as the only iron source relative to that found when transferrin is the sole iron
source (87).
Although purely speculative, the possibility of heme bound to the Hbps acting as a CO
sensor is intriguing. Carbon monoxide is a potent second messenger molecule in the
human body that increases expression of the anti-inflammatory cytokine, IL-10, in
macrophages (19). Interestingly, cytokine profiles obtained from homeless people with
chronic B. quintana bacteremia show a specific increase in IL-10 secretion that is
believed to contribute to bacterial persistence (29). Thus while CO may signal an antiinflammatory state in the human host it seems plausible that it may also serve as a signal
to the bacterium indicating an environment conducive to the establishment of bacteremia.
Alternatively, it has been hypothesized that the Hbps may induce a microaerobic
environment by binding O2, or serve as a surface hemin storage site. Regardless of their
actual function(s), the Hbp-hemin interaction represents a fascinating aspect of
Bartonella biology that clearly warrants future study.
The transcriptional response of the hbps served as the impetus for study of hemin
and/or iron-responsive gene regulation. The identification of a Fur homolog in B.
quintana led to the investigation of this protein as the potential mediator of heminresponsive transcriptional control of the hbpgenes (131). B. quintana fur is in a unique
arrangement relative to the fur gene of other bacterial species in that it is 17 bp
downstream from the secA gene encoding the ATPase component of the general secretory
pathway (182). Although B. quintana fur encodes a functional repressor that recognizes
the E. coli “Fur box” consensus sequence when recombinantly expressed under control of
an exogenous promoter, no support for endogenous promoter activity or in vivo
expression was obtained in these studies. These data add to a growing body of evidence
that challenges the γ-proteobacterial model of Fur as the primary iron-responsive gene
regulator by showing that its role is lessened or even absent in α-proteobacteria (148). It
is within the realm of possibility that B. quintana fur is expressed under some
undetermined condition, perhaps requiring a novel Bartonella-specific sigma factor. In
support of this possibility, forced overexpression of Fur in B. quintana resulted in
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decreased transcription of hbpC and tonB relative to control strains (14). As the gut of
the body louse is expected to have the highest concentration of free hemin, it would be
interesting to examine fur expression, perhaps using the fur promoter-gfp fusion
constructs described by Parks et al, in B. quintana during a louse infection (131).
The inability to identify a native promoter for fur led to investigation of the Fur
superfamily transcriptional regulator, Irr. Although attempts to generate an irr knockout
were not successful, Irr overexpression in B. quintana resulted in a “bloodstream-like”
profile of hbp transcription. Specifically, hbpA, D, and E transcript levels were increased
relative to that observed in controls. Additionally, purified recombinant Irr was shown to
bind to a conserved motif found in the promoter region of the hbps, termed the H-box
(14). These data, combined with the absence of a role for Fur, suggest that Irr has
assumed the role of primary hemin-responsive transcriptional regulator in Bartonella. It
would be interesting to examine the effects of Irr overexpression on the B. quintana
genome to see if it also regulates potential virulence determinants.
Upon successfully identifying a major transcriptional regulator of the hbp genes,
efforts were refocused on identification of the principal hemin uptake system of B.
quintana. By genomic analyses, the hut locus was chosen as the most likely candidate.
The ability of HutA to function as a hemin receptor was confirmed by complementation
assays using an E. coli strain unable to either synthesize or import porphyrin.
Complementation assays were also used to establish the TonB-dependence of HutAmediated hemin transport. Both the structure of HutA and the genetic organization of the
hut locus are remarkably similar to hemin acquisition systems described in other Gramnegative bacteria (165). The extensive conservation found in bacterial hemin uptake
systems makes them attractive candidates for the generation of new antibiotics. At least
one study has examined the possibility of exploiting bacterial hemin/hemoglobin uptake
systems for the delivery of non-iron metalloporphyrins. Gallium protoporphyrin IX was
toxic to a range of bacterial pathogens, but relatively well tolerated by human fibroblasts
and a mouse model (167). This report provides preliminary evidence confirming the
viability of exploiting hemin acquisition systems as an antimicrobial approach.
Based on its function as a hemin transport system, the hut locus was expected to be
transcriptionally responsive to alterations in available hemin and this was confirmed by
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qRT-PCR. Surprisingly, the relative difference in transcription levels was modest despite
the fact that samples were obtained from bacteria grown on media supplemented with
enormously different hemin concentrations. These relatively small changes in hut locus
transcription could hypothetically result from the existence of a hemin-storage reservoir
or another buffering system.
B. quintana strains overexpressing Irr, Fur, and RirA, were used to investigate the
transcriptional regulation of the hut locus. Irr was identified as the primary mediator of
transcriptional changes in the hut locus, even though Fur overexpression did result in
decreased transcription of tonB when strains were grown in the presence of excess hemin.
Unlike the hbp genes, some of which were induced by overexpression of Irr, the hut locus
genes were repressed by Irr overexpression at all hemin concentrations tested. These
observations suggest that Irr is able to function as both an inducer and a repressor in B.
quintana. A similar situation has been reported in Bradyrhizobium japonicum, where the
effect of Irr is a function of the location of the binding motif, termed an iron control
element (ICE), relative to the start of the gene (149). In accordance with these
observations, consensus sequences similar to the H-box were identified in the hutA/tonB
promoter region and in the hemS promoter region. These sites overlap the predicted -10/35 promoter site of hutA and the predicted -35 promoter site of hemS. In contrast, the Hbox identified in the promoter region of the hbp family members is at least 50 bp
upstream of the start of the gene (14). Thus, these data appear to fit the B. japonicum
model where Irr functions as a repressor when bound near the transcriptional start site of
a gene and an inducer when bound farther upstream. As the consensus sequence
encompassing the H-box is fairly large, an interesting area of future research would be to
refine the motif to essential nucleotides by DNase footprinting and/or site-directed
mutagenesis using a reporter gene fused to a promoter that contains the H-box.
While the majority of the Hut locus proteins have obvious roles, HemS is the subject
of some controversy. Numerous functions have been attributed to HemS homologs in
other bacterial species including DNA binding, heme trafficking and heme sequestration
(90, 91, 191). The most interesting function for these proteins is a heme oxygenase
activity attributed to the E. coli homolog, ChuS (169). The possibility that B. quintana
HemS functions as heme oxygenase is interesting for several reasons. First, no heme
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oxygenase with similarity to human HO-1, and therefore the major class of bacterial HO,
is evident in the B. quintana genome. Second, although systems with homology to ferric
iron uptake (yfeA-D) and siderophore transport (fatB-D) are present in the genome, iron
supplied with protoporphyrin IX is not adequate to support in vitro growth of Bartonella
(152), nor are genes encoding a siderophore biosynthesis system readily apparent (Battisti
and Minnick, unpublished data). Third, even if Bartonella is able to acquire free iron, its
availability in human erythrocytes is expected to be negligible. Fourth, B. quintana has a
marked absence of genes encoding iron-storage molecules (13). Collectively these
observations suggest an undefined mechanism in the acquisition of iron by B. quintana.
Clearly, the presence of a HO would provide an iron source as long as heme was
available. Finally, ChuS, and by default HemS, has no structural similarity to any known
HO but has homologs in a number of bacterial pathogens. Given the scarcity of iron in
the human host, inhibition of a unique HO presents an ideal target for therapeutic
intervention.
Experiments to date have shown that HemS binds hemin with a 1:1 stoichiometry.
The absence of enzymatic activity in in vivo experiments may result from the strain used
for complementation analyses and in in vitro experiments may result from either the
mutation in the His6-HemS construct or the relatively low concentration of protein used
in the experiments. Alternatively, Suits et al. reported that fresh ChuS was required to
prevent aggregation (168). However, generating sufficient amounts of HemS for in vitro
examination of enzymatic activity without stockpiling several preparations would be
problematic with the current construct. An alternative and possibly more sensitive in
vitro approach consists of measuring the release of 55Fe from [55Fe] protoporphyrin IXα
(136). However, this method may be a last resort due to the expense associated with
obtaining radiolabeled hemin. The identification of a chuS mutant in E. coli 0157:H7 is a
promising avenue for examining the ability of HemS to function as a HO in vivo and the
generation of a suitable construct for initiation of these studies is currently underway.
In summary, the studies described herein were undertaken with the aim of identifying
the mechanism and regulation of hemin acquisition in B. quintana. Data obtained from
these studies have paved the way for further characterization of the Hbp family of
proteins, which do not appear to function as hemin receptors but may serve an accessory
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role in hemin acquisition. These studies have also contributed to the generation of a new
model of iron and hemin-responsive transcriptional regulation whereby the
transcriptional control provided by the Fur protein in γ-proteobacteria is provided by the
related Irr protein in α-proteobacteria. The primary hemin acquisition system of B.
quintana was identified and shown to be under transcriptional control of Irr. Initial
examination of the function of HemS has been undertaken and several difficulties that
need to be addressed in order to further investigate the function of this enzyme have been
identified. Numerous questions regarding hemin acquisition and utilization in Bartonella
remain. Arguably, the most interesting of these include the function of the Hbps and the
fate of hemin upon delivery to the cytosol. The answers to these questions, combined
with the results presented here, will enhance understanding of the ability of these unique
pathogens to cause disease in the human host.
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